Wolter_Sucht im Alter_WEB-Literatur_AK_4 1..45

Transcrição

Dirk K. Wolter: Sucht im Alter – Altern und Sucht
Abdullah AS, Ho LM, Kwan YH, Cheung WL, McGhee SM, Chan WH (2006): Promoting
smoking cessation among the elderly: what are the predictors of intention to quit and
successful quitting? J Aging Health 18(4): 552 – 564.
Abdullah AS, Lam TH, Chan SK, Leung GM, Chi I, Ho WW, Chan SS (2008): Effectiveness
of a mobile smoking cessation service in reaching elderly smokers and predictors of
quitting. BMC Geriatr 8: 25. DOI: 10 1186/1471 – 2318 – 8-25.
Abraham AG, Condon NG, West Gower E (2006): The new epidemiology of cataract.
Ophthalmol Clin North Am 19(4): 415 – 425.
Ackermann A (2006): Prvention. In: Oswald WD, Lehr U, Sieber C, Kornhuber J (Hrsg.):
Gerontologie. Medizinische, psychologische und sozialwissenschaftliche Grundbegriffe.
Stuttgart: Kohlhammer. 3. Aufl. S. 285 – 290.
Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE
(2006): A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in
patients with chronic pain. J Pain Symptom Manage 31(5): 465 – 476.
Adams WL, Magruder-Habib K, Trued S, Broome HL (1992): Alcohol abuse in elderly
emergency department patients. J Am Geriatr Soc 40: 1236 – 1240.
Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, Gessa
GL, Gasbarrini G (2006): Baclofen in the treatment of alcohol withdrawal syndrome: a
comparative study vs diazepam. Am J Med 119(3): e13–e18.
Adler G (2005): Verhaltenstherapeutische-Einzelpsychotherapie von Depressionen im Alter
(VEDIA). Stuttgart: Schattauer.
Adlkofer F (2000): Tabak. In: Uchtenhagen A, Zieglgnsberger W (Hrsg.): Suchtmedizin.
Mnchen: Urban & Fischer. S. 39 – 53.
Agabio R (2005): Thiamine administration in alcohol-dependent patients. Alcohol Alcohol
40: 155 – 156.
Agarwal S, Polydefkis M, Block B, Haythornthwaite J, Raja SN (2007): Transdermal
fentanyl reduces pain and improves functional activity in neuropathic pain states. Pain
Med 8(7): 5545 – 5562.
Ait-Daoud N, Lynch WJ, Penberthy JK, Breland AB, Marzani-Nissen GR, Johnson BA
(2006): Treating smoking dependence in depressed alcoholics. Alcohol Res Health 29(3):
213 – 220.
Allard J, Artero S, Ritchie K (2003): Consumption of psychotropic medication in the
elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry
18(10): 874 – 878.
Allen SC (2008): What determines the ability to stop smoking in old age? Age Ageing 37(5):
490 – 491.
Allen SS, Hatsukami D, Brintnell DM, Bade T (2005): Effect of nicotine replacement
therapy on post-cessation weight gain and nutrient intake: a randomized controlled trial
of postmenopausal female smokers. Addict Behav 30(7): 1273 – 1280.
Almeida OP, Pfaff JJ (2005): Depression and smoking amongst older general practice
patients. J Affect Disord 86(2 – 3): 317 – 321.
Amato L, Minozzi S, Pani PP, Davoli M (2007): Antipsychotic medications for cocaine
dependence. Cochrane Database Syst Rev (3):CD006 306.
1
© 2010 W. Kohlhammer, Stuttgart
Literatur – Vervollstndigung
American Medical Association (Council on Scientific Affairs) (1996): Alcoholism in the
Elderly. JAMA 275: 797 – 801.
Ammon HPT (2001): Arzneimittelneben- und Wechselwirkungen. Stuttgart: Wissenschaftliche Verlagsgesellschaft. 4. Aufl.
Anderson TL, Levy JA (2003): Marginality among older injectors in today’s illicit drug
culture: assessing the impact of ageing. Addiction 98(6): 761 – 770.
Andreas A, Batra A, Behr J, Berck H, Chenot JF, Gillissen A, Hering T, Herth F, Meierjrgen R, Mhlig S, Nowak D, Pfeifer M, Raupach T, Schultz K, Sitter H, Worth H
(2008): Tabakentwçhnung bei COPD (AWMF-Leitlinie). Pneumologie 62: 255 – 272
(http://www.awmf-leitlinien.de/unter „Pneumologie“).
Andreas S, Hering T, Mhlig S, Nowak D, Raupach T, Worth H (2009): Tabakentwçhnung
bei chronisch obstruktiver Lungenerkrankung. Dtsch Arztebl Int 106(16): 276 – 282.
Andrews JO, Heath J, Graham-Garcia J (2004): Management of tobacco dependence in
older adults: using evidence-based strategies. J Gerontol Nurs 30(12): 13 – 24.
Anttila T, Helkala E-L, Viitanen M, Kåreholt I, Fratiglioni L, Winblad B, Soininen H,
Tuomilehto J, Nissinen A, Kivipelto M (2004): Alcohol drinking in middle age and
subsequent risk of mild cognitive impairment and dementia in old age: a prospective
population based study. BMJ 329: 539 – 542.
APA – American Psychiatric Association (2010): DSM-5 Proposed Revisions Include New
Category of Addiction and Related Disorders. New Category of Behavioral Addictions
Also Proposed. http://www.dsm5.org/Newsroom/Documents/Addiction%20release%20FINAL%202.05.pdf – Zugriff 30. 04. 2010.
Apelt S, Schmauss C, Emrich HM (1992): Psychopharmakologie und Klinik der Benzodiazepin-Abhngigkeit. Fortschr Neurol Psychiat 60: 104 – 109.
Arndt S, Gunter TD, Acion L (2005): Older admissions to substance abuse treatment in
2001. Am J Geriatr Psychiatry 13(5): 385 – 392.
Ashton H (1987): Benzodiazepine Withdrawal: Outcome in 50 Patients. Br J Addict 82:
665 – 671.
Ashton H (1991): Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse
Treat 8: 19 – 28.
Ashton H (2005): The diagnosis and management of benzodiazepine dependence. Curr
Opin Psychiatry 18(3): 249 – 255.
Augst G (1998): Wortfamilienwçrterbuch der deutschen Gegenwartssprache. Tbingen:
Niemeyer.
Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M (2008): Nortriptyline plus
nicotine replacement versus placebo plus nicotine replacement for smoking cessation:
pragmatic randomised controlled trial. BMJ 336(7655): 1223 – 1237.
Ayalon L, Gum AM, Feliciano L, Aren PA (2006): Effectiveness of nonpharmacological
interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 166(20): 2182 – 2188.
Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Grgoire JP, Morin CM (2003):
Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ
169(10): 1015 – 1020.
Baillie AJ, Mattick RP (1996): The Benzodiazepine Questionnaire: Development, Reliability and Validity. Br J Psychiatry 169: 276 – 281.
BK (2010): Richtlinien der Bundesrztekammer zur Durchfhrung der substitutionsgesttzten Behandlung Opiatabhngiger vom 19. 02. 2010. http://www.bundesaerztekammer.de/page.asp?his=3.71.796280728073 – Zugriff 30. 04. 2010.
2
Literatur
Bakken K, Landheim AS, Vaglum P (2003): Primary and secondary substance misusers: do
they differ in substance-induced and substance-independent mental disorders? Alcohol
Alcohol 38(1): 54 – 59.
Balfour DJK (2005): Biologische Aspekte des Rauchens. In: Batra A (Hrsg.): Tabakabhngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart: Kohlhammer.
S. 42 – 52.
Ballantyne JC (2006): Opioids for chronic nonterminal pain. South Med J 99(11):
1245 – 1255.
Barker MJ, Greenwood K, Jackson M, Crowe SF (2004 b): Persistence of cognitive effects
after withdrawal from long-term benzodiazepine-use: a meta-analysis. Arch Clin Neuropsychology 19: 437 – 454.
Barker MJ, Greenwood K, Jackson M, Crowe SF (2005): An evaluation of persisting
cognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsychol Soc 11(3): 281 – 289.
Barnas C, Miller C, Ehrmann H, Schett P, Gunther V, Fleichhacker WW (1990): High
versus low-dose piracetam in alcoholic organic mental disorder. Psychopharmacology
100: 361 – 365.
Barnas C, Whitworth AB, Fleischhacker WW (1993): Are Patterns of Benzodiazepine Use
Predictable? A Follow-Up-Study of Benzodiazepine Users. Psychopharmacol 111:
301 – 305.
Barrick C, Connors GJ (2002): Relapse prevention and maintaining abstinence in older
adults with alcohol-use disorders. Drugs Aging 19(8): 583 – 594.
Bartels SJ, Blow FC, Brockmann LM, Van Citters AD (2005): Substance Abuse and Mental
Health Among Older Americans: The State of the Knowledge and Future Directions.
Rockville, MD: Older American Substance Abuse and Mental Health Technical Assistance Center, Substance Abuse and Mental Health Services Administration. http://
www.samhsa.gov/OlderAdultsTAC/SA_MH_%20AmongOlderAdultsfinal102105.pdf –
Zugriff 30. 04. 2010.
Bartzokis G, Beckson M, Hance DB, Lu PH, Foster JA, Mintz J, Ling W, Bridge P (1999):
Magnetic resonance imaging evidence of „silent“ cerebrovascular toxicity in cocaine
dependence. Biol Psychiatry 45(9): 1203 – 1211.
Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P (2000):
Age-related brain volume reductions in amphetamine and cocaine addicts and normal
controls: implications for addiction research. Psychiatry Res 98(2): 93 – 102.
Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz J (2002): Brain maturation
may be arrested in chronic cocaine addicts. Biol Psychiatry 51(8): 605 – 611.
Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Bridge P, Mintz J (2004):
Cortical gray matter volumes are associated with subjective responses to cocaine infusion. Am J Addict 13(1): 64 – 73.
Basu R, Dodge H, Stoehr GP, Ganguli M (2003): Sedative-hypnotic use of diphenhydramin
in a rural, older adult, community-based cohort. Am J Geriatr Psychiatry 11: 205 – 213.
Batra A (2009): Rauchen – Krankheit oder Lifestyle? Dtsch Arztebl Int 106(27): 449 – 450.
Batra A, Buchkremer G (2004): Tabakentwçhnung. Ein Leitfaden fr Therapeuten. Stuttgart: Kohlhammer.
Batra A, Buchkremer G (Hrsg.) (2008): Nichtrauchen! Erfolgreich aussteigen in sechs
Schritten. Stuttgart: Kohlhammer. 2. Aufl.
Batra A, Rieß O (2005): Auf der Suche nach dem „Tabakgen“ – existiert eine genetische
Grundlage des Rauchens? In: Batra A (Hrsg.): Tabakabhngigkeit. Wissenschaftliche
Grundlagen und Behandlung. Stuttgart: Kohlhammer. S. 53 – 63.
3
Batty GM, Oborne CA, Swift CG, Jackson SHD (2000): Development of an indicator to
identify inappropriate use of benzodiazepines in elderly medical inpatients. Int J Geriatr
Psychiatry 15: 892 – 896.
Burle P, Radebold H, Hirsch RD, Studer K, Schmid-Furstoss U, Struwe B (Hrsg.) (2000):
Klinische Psychotherapie mit lteren Menschen. Bern: Huber.
Burle P, Fçrstl H, Hell D, Radebold H, Riedel I, Studer K (Hrsg.) (2005): Spiritualitt und
Kreativitt in der Psychotherapie mit lteren Menschen. Bern: Huber.
Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF (2009):
Altered white matter microstructure in adolescent substance users. Psychiatry Res
173(3): 228 – 237.
Beatty WW, Tivis R, Stott HD, Nixon SJ, Parsons OA (2000): Neuropsychological deficits
in sober alcoholics: influences of chronicity and recent alcohol consumption. Alcohol
Clin Exp Res 24: 149 – 154.
Beaudreau SA, Spira AP, Gray HL, Depp CA, Long J, Rothkopf M, Gallagher-Thompson D
(2008): The relationship between objectively measured sleep disturbance and dementia
family caregiver distress and burden. J Geriatr Psychiatry Neurol 21(3): 159 – 165.
Becerra L, Harter K, Gonzalez RG, Borsook D (2006): Functional magnetic resonance
imaging measures of the effects of morphine on central nervous system circuitry in
opioid-naive healthy volunteers. Anesth Analg 103(1): 208 – 216.
Blanger L, Morin CM, Bastien C, Ladouceur R (2005): Self-efficacy and compliance with
benzodiazepine taper in older adults with chronic insomnia. Health Psychol 24 (3):
281 – 287.
Bell CM, Fischer HD, Gill SS, Zagorski B, Sykora K, Wodchis WP, Herrmann N, Bronskill
SE, Lee PE, Anderson GM, Rochon PA (2007): Initiation of benzodiazepines in the
elderly after hospitalization. J Gen Intern Med 22(7): 1024 – 1029.
Belleville G, Guay C, Guay B, Morin CM (2007): Hypnotic taper with or without self-help
treatment of insomnia: a randomized clinical trial. J Consult Clin Psychol 75(2):
325 – 335.
Benkert O, Hippius H, Wetzel H, Grnder G (1996): Psychiatrische Pharmakotherapie.
Berlin: Springer. 6. Aufl.
Beracochea D (2006): Anterograde and retrograde effects of benzodiazepines on memory.
Scientific World Journal 16(6): 1460 – 1465.
Bergener M, Hampel H, Mçller HJ, Zaudig M (Hrsg.) (2005): Gerontopsychiatrie. Stuttgart: Wissenschaftl. Verlagsgesellschaft.
Berger T (2000): Nervensystem. In: Zernig G, Saria A, Kurz M, O’Malley SS (Hrsg.):
Handbuch Alkoholismus. Universittsklinik fr Psychiatrie Innsbruck. S. 205 – 214.
Berggren U, Berglund K, Fahlke C, Aronsson E, Eriksson M, Balldin J (2007): Tobacco use
is associated with more severe alcohol dependence, as assessed by the number of DSM-IV
criteria, in Swedish male type 1 alcoholics. Alcohol Alcohol 42(3): 247 – 251.
Berndt S, Maier C, Schtz H-W (1993): Polymedication and medication in patients with
chronic non malignant pain. Pain 52: 331 – 339.
Berner MM, Kriston L, Bentele M, Hrter M (2007): The Alcohol Use Disorders Identification Test for Detecting At-Risk Drinking: A Systematic Review and Meta-Analysis.
J Stud Alcohol Drugs 68(3): 461 – 473.
Bertz RJ, Kroboth PD, Kroboth FJ, Reynolds IJ, Salek F, Wright CE, Smith RB (1997):
Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative
and memory effects. J Pharmacol Exp Ther 281(3): 1317 – 1329.
Berzewski H (1986): Risiken und Komplikationen bei der Behandlung des alten Menschen
mit Benzodiazepinen. In: H Hippius, RR Engel, G Laakmann (Hrsg.): Benzodiazepine.
Rckblick und Ausblick. Berlin: Springer. S. 121 – 130.
4
Literatur
Beske F (2010): Bedarfsgerechte Gesundheitsversorgung bei begrenzten Mitteln. Situationsanalyse, internationaler Vergleich, Handlungsoptionen. Kiel: Institut fr GesundheitsSystem-Forschung.
Beynon CM, McVeigh J, Roe B (2007): Problematic drug use, ageing and older people:
trends in the age of drug users in northwest England. Ageing Soc 27: 799 – 810.
Beynon CM, McVeigh J, Hurst A, Marr A (2010): Older and sicker: Changing mortality of
drug users in treatment in the North West of England. International Journal of Drug
Policy. DOI: 10 1016/j.drugpo.2010. 01. 012.
Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF (2007):
The effects of chronic benzodiazepine use on cognitive functioning in older persons:
good, bad or indifferent? Int J Geriatr Psychiatry 22: 1194 – 1200.
Bilitza KW (Hrsg.) (2009 c): Psychodynamik der Sucht. Psychoanalytische Beitrge zur
Theorie. Gçttingen: Vandenhoeck & Ruprecht. 2. Aufl.
Bilitza KW (Hrsg.) (2009 d): Psychotherapie der Sucht. Psychoanalytische Beitrge zur
Praxis. Gçttingen: Vandenhoeck & Ruprecht. 2. Aufl.
Bize R, Burnand B, Mueller Y, Cornuz J (2007): Effectiveness of biomedical risk assessment
as an aid for smoking cessation: a systematic review. Tob Control 16(3): 151 – 156.
Bize R, Burnand B, Mueller Y, Rge Walther M, Cornuz J (2009): Biomedical risk assessment as an aid for smoking cessation (Review). Cochrane Database Syst Rev Issue 2. Art.
No.: CD004 705. DOI: 10 1002/14 651 858.CD004 705.pub3.
Bjartveit K, Tverdal A (2005): Health consequences of smoking 1 – 4 cigarettes per day. Tob
Control 14(5): 315 – 320.
Bjartveit K, Tverdal A (2009): Health consequences of sustained smoking cessation. Tob
Control 18(3): 197 – 205.
Blazer DG, Wu LT (2009 a): The Epidemiology of At-Risk and Binge Drinking Among
Middle-Aged and Elderly Community Adults: National Survey on Drug Use and Health.
Am J Psychiatry 166: 1162 – 1169.
Blazer DG, Wu LT (2009 b): The epidemiology of substance use and disorders among
middle aged and elderly community adults: national survey on drug use and health.
Am J Geriatr Psychiatry 17(3): 237 – 245.
Bleich S, Bandelow B, Javaheripour K, Mller A, Degner D, Wilhelm J, Havemann-Reinecke U, Sperling W, Rther E, Kornhuber J (2003 a): Hyperhomocysteinemia as a new
risk factor for brain shrinkage in patients with alcoholism. Neurosci Lett 335: 179 – 182.
Bleich S, Sperling W, Wiltfang J, Maler JM, Kornhuber J (2003 b): Exzitatorische Neurotransmission bei chronischem Alkoholismus. Fortschr Neurol Psychiat 71 (Suppl):
S36–S44.
Blow FC, Brockmann LM, Barry KL (2004): Role of alcohol in late-life suicide. Alcohol
Clin Exp Res 28(5 Suppl): 48S–56S.
BMFSFJ – Bundesministerium fr Familie, Senioren, Frauen und Jugend (1988): Empfehlungen der Expertenkommission der Bundesregierung zur Reform der Versorgung im
psychiatrischen und psychotherapeutisch/psychosomatischen Bereich. Bonn.
BMFSFJ – Bundesministerium fr Familie, Senioren, Frauen und Jugend (2002): Vierter
Bericht zur Lage der lteren Generation in der Bundesrepublik Deutschland. Risiken,
Lebensqualitt und Versorgung Hochaltriger – unter besonderer Bercksichtigung
dementieller Erkrankungen. Bonn.
Boddiger D (2008): Drug abuse in older US adults worries experts. Lancet 372(9650):
1622.
Bond GE, Burr RL, McCurry SM, Rice MM, Borenstein AR, Larson EB (2005): Alcohol
and cognitive performance: a longitudinal study of older Japanese Americans. The Kame
Project. Int Psychogeriatr 17: 653 – 668.
5
Bonnet U, Gastpar M (1999): Opioide. In: Gastpar M, Mann K, Rommelspacher H
(Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 237 – 262.
Bonnet U, Banger M, Leweke FM, Specka M, Mller BW, Hashemi T, Nyhuis PW, Kutscher S, Burtscheidt W, Gastpar M (2003): Treatment of acute alcohol withdrawal with
gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol 23(5):
514 – 519.
Bçning J, Schrappe O (1984): Benzodiazepin-Abhngigkeit: Klinik der Entzugssyndrome.
Dtsch rztebl 81: 279 – 285.
Borscheid P (1994): Der alte Mensch in der Vergangenheit. In: Baltes PB, Mittelstraß J,
Staudinger UM (Hrsg.): Alter und Altern. Ein interdisziplinrer Studientext zur Gerontologie. Berlin: de Gruyter. S. 35 – 61.
Borucki K, Schreiner R, Dierkes J, Jachau K, Krause D, Westphal S, Wurst FM, Luley C,
Schmidt-Gayk H (2005): Detection of Recent Ethanol Intake With New Markers: Comparison of Fatty Acid Ethyl Esters in Serum and of Ethyl Glucuronide and the Ratio of
5-Hydroxytryptophol to 5-Hydroxyindole Acetic Acid in Urine. Alcohol Clin Exp Res
29: 781 – 787.
Botella-Carretero JI, Escobar-Morreale HF, Martn I, Valero AM, Alvarez F, Garca G,
Varela C, Cantarero M (2004): Weight gain and cardiovascular risk factors during
smoking cessation with bupropion or nicotine. Horm Metab Res 36(3): 178 – 182.
Bowden SC (1990): Separating cognitive impairment in neurologically asymptomatic alcoholics from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified? Psychol Bull 107: 355 – 366.
Boyle RG, Solberg LI, Magnan S, Davidson G, Alesci NL. (2002): Does insurance coverage
for drug therapy affect smoking cessation? Health Affairs 21(6): 162.
Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR (2007):
AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res
31(7): 1208 – 1217.
Bramness JG, Skurtveit S, Mørland J (2006): Flunitrazepam: psychomotor impairment,
agitation and paradoxical reactions. Forensic Sci Int 159(2 – 3): 83 – 91.
Brandenberg C, Nehen HG (2010): Die Belastung pflegender Angehçriger, eine Vergleichsuntersuchung in den Jahren 1998 und 2007. (In Vorbereitung)
Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S (2008): The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis 27(3):
37 – 48.
Brandtstdter J, Lindenberger U (Hrsg.) (2007): Entwicklungspsychologie der Lebensspanne. Ein Lehrbuch. Stuttgart: Kohlhammer.
Brega AG, Grigsby J, Kooken R, Hamman RF, Baxter J (2008): The impact of executive
cognitive functioning on rates of smoking cessation in the San Luis Valley Health and
Aging Study. Age Ageing 37(5): 521 – 525.
Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H (2009): Aufhçrversuche
und -wille bei lteren Rauchern. Epidemiologische Beitrge zur Diskussion um „Lifestyle“ versus „Sucht“. Dtsch Arztebl Int 106(27): 451 – 455. DOI: 10 3238/arztebl.2 009 0451.
Brennan PL, Nichols KA, Moos RH (2002): Long-term use of VA mental health services by
older patients with substance use disorders. Psychiatr Serv 53(7): 836 – 841.
Brennan PL, Schutte KK, Moos RH (2005): Pain and use of alcohol to manage pain:
prevalence and 3-year outcomes among older problem and non-problem drinkers.
Addiction 100(6): 777 – 786.
Breslau N, Johnson EO (2000): Predicting smoking cessation and major depression in
nicotine-dependent smokers. Am J Public Health 90(7): 1122 – 1127.
6
Literatur
Brinker A, Beitz RABJ, Yates WR (2002): Abuse, dependence, or withdrawal associated
with tramadol/Dr. Yates replies. Am J Psychiatry 159(5): 881.
Brokate B, Hildebrandt H, Elling P, Fichtner H, Runge K, Timm C (2003): Frontal lobe
dysfunctions in Korsakoff’s syndrome and chronic alcoholism: continuity or discontinuity? Neuropsychology 17: 420 – 428.
Brower KJ, Mudd S, Blow FC, Young JP, Hill EM (1994): Severity and treatment of alcohol
withdrawal in elderly versus younger patients. Alcohol Clin Exp Res 18(1): 196 – 201.
Brown DW, Croft JB, Schenck AP, Malarcher AM, Giles WH, Simpson RJ Jr (2004):
Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am
J Prev Med 26(2): 112 – 118.
Brown RT, Zuelsdorff M, Fleming M (2006): Adverse effects and cognitive function among
primary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag
2(3): 137 – 146.
Bruder J (1989): Suchtmittelgebrauch und Suchtmittelmissbrauch im Alter aus gerontologischer Sicht. In: Abhngigkeit im Alter. Mçglichkeiten und Grenzen der Hilfe. Hamburg: Hamburgische Landesstelle gegen die Suchtgefahren. S. 7 – 16.
Brun A, Andersson J (2001): Frontal dysfunction and frontal cortical synapse loss in
alcoholism – the main cause of alcohol dementia? Dement Geriatr Cogn Disord 12:
289 – 294.
Bchner U (2009): Der Rckfall im diagnostischen und therapeutischen Prozess. In: Bilitza
KW (Hrsg.): Psychotherapie der Sucht. Psychoanalytische Beitrge zur Praxis. Gçttingen:
Vandenhoeck & Ruprecht. 2. Aufl. S. 179 – 190.
Buffett-Jerrott SE, Stewart SH, Bird S, Teehan MD (1998): An examination of differences
in the time course of oxazepam’s effects on implicit vs explicit memory. J Psychopharmacol 12(4): 338 – 347.
Bhringer G, Augustin R, Bergmann E, Bloomfield K, Funk W, Junge B, Kraus L, MerfertDiete C, Rumpf HJ, Simon R, Tçppich J (2000): Alkoholkonsum und Alkoholbezogene
Stçrungen in Deutschland. Schriftenreihe des BMG, Band 128. Baden-Baden: Nomos.
Bhringer P (2010): Priorisierung in Psychiatrie und Psychotherapie. Gegen heimliche
Rationierungen. Dtsch Arztebl 107(6): A-226/B-205/C-201.
Burnette MM, Meilahn E, Wing RR, Kuller LH (1998): Smoking cessation, weight gain,
and changes in cardiovascular risk factors during menopause: the Healthy Women Study.
Am J Public Health 88(1): 93 – 96.
Burns A (2004): Psychological and behavioural interventions in dementia. Curr Opin Psychiatry 17: 433 – 437.
Burns DM (2003 a): Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 46(1): 11 – 29.
Burns DM (2003 b): Tobacco-related diseases. Semin Oncol Nurs 19(4): 244 – 249.
Burns DM (2008): Live Fast, Die Young, Leave a Good-looking Corpse. Arch Intern Med
1946 – 1947.
Busto UE, Sykora K, Sellers EM (1989): A clinical scale to assess benzodiazepine withdrawal. J Clin Psychopharmacol 9(6): 412 – 416.
Bø K, Thoresen M, Dalgard F (2008): Smokers report more psoriasis, but not atopic
dermatitis or hand eczema: results from a Norwegian population survey among adults.
Dermatology 216(1): 40 – 45.
Cahill K, Perera R (2008): Competitions and incentives for smoking cessation. Cochrane
Database Syst Rev Issue 3. Art. No.: CD004 307. DOI: 101002/14651858.CD004307.pub3.
7
Cahill K, Stead LF, Lancaster T (2008): Nicotine receptor partial agonists for smoking
cessation. Cochrane Database Syst Rev Issue 3. Art. No.: CD006 103. DOI:
01002/14 651 858.CD006 103.pub3.
Caldarone BJ, King SL, Picciotto MR (2008): Sex differences in anxiety-like behavior and
locomotor activity following chronic nicotine exposure in mice. Neurosci Lett 439(2):
187 – 191.
Cantopher T, Olivieri S, Cleave N, Edwards JG (1990): Chronic benzodiazepine dependence. A comparatative study of abrupt withdrawal under propranolol cover versus
gradual withdrawal. Br J Psychiatry 156: 406 – 411.
Cargill BR, Emmons KM, Kahler CW, Brown RA (2001): Relationship among alcohol use,
depression, smoking behavior, and motivation to quit smoking with hospitalized smokers. Psychol Addict Behav 15(3): 272 – 275.
Carlen PL, McAndrews MP, Weiss RT, Dongier M, Hill JM, Menzano E, Farcnick K,
Abarbanel J, Eastwood MR (1994): Alcohol-related dementia in the institutionalized
elderly. Alcohol Clin Exp Res 18: 1330 – 1334.
Carlsten A, Waern M (2009): Are sedatives and hypnotics associated with increased suicide
risk of suicide in the elderly? BMC Geriatr 4(9): 20.
Chaney SE, Sheriff S (2008): Weight gain among women during smoking cessation: testing
the effects of a multifaceted program. AAOHN J 56(3): 99 – 105.
Chang L, Chronicle EP (2007): Functional imaging studies in cannabis users. Neuroscientist 13(5): 422 – 432.
Chen CY, Lin KM (2009): Health consequences of illegal drug use. Curr Opin Psychiatry
22(3): 287 – 292.
Chen Y, Horne SL, Dosman JA (1993): The influence of smoking cessation on body weight
may be temporary. American Journal of Public Health 83(9): 1330 – 1332.
Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, Ant JM, Cerveri I, de
Marco R, Gislason T, Heinrich J, Janson C, Knzli N, Leynaert B, Neukirch F, Schouten
J, Sunyer J, Svanes C, Vermeire P, Wjst M, Burney P (2005): Smoking cessation, lung
function, and weight gain: a follow-up study. Lancet 365(9471): 1629 – 1635.
Chiolero A, Faeh D, Paccaud F, Cornuz J (2008): Consequences of smoking for body
weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4): 801 – 809.
Christo PJ, Grabow TS, Raja SN (2004): Opioid effectiveness, addiction, and depression in
chronic pain. Adv Psychosom Med 25: 123 – 137.
Clark MA, Rakowski W, Kviz FJ, Hogan JW (1997): Age and stage of readiness for
smoking cessation. J Gerontol B Psychol Sci Soc Sci 52(4): S212–S221.
Clarke PR, Eccersley PS, Frisby JP, Thornton JA (1970): The amnesic effect of diazepam
(Valium). Br J Anaest 42(8): 690 – 697.
Clipp EC, George LK (1990): Psychotropic Drug Use Among Caregivers of Patients With
Dementia. J Am Geriatr Soc 38: 227 – 235.
Closs C, Lal A (1990): Suchtkrankenhilfe fr alte Menschen in Heimen und Krankenhusern. In: Alter und Sucht. Hamburg: Hamburgische Landesstelle gegen die Suchtgefahren. S. 53 – 58.
Cochrane M, Cochrane A, Jauhar P, Ashton E (2005): Acetylcholinesterase inhibitors for
the treatment of Wernicke-Korsakoff syndrome – three further cases show response to
donepezil. Alcohol Alcohol 40: 151 – 154.
Cole JO, Kando JC (1993): Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. J Clin Psychiatry 54 (Suppl): 49 – 61.
Collins N, Sachs-Ericsson N, Preacher KJ, Sheffield KM, Markides K (2009): Smoking
Increases Risk for Cognitive Decline Among Community-Dwelling Older Mexican Americans. Am J Geriatr Psychiatry 17: 934 – 942.
8
Literatur
Colliver JD, Compton WM, Gfroerer JC, Condon T (2006): Projecting drug use among
aging baby boomers in 2020. Ann Epidemiol 16(4): 257 – 265.
Colzato LS, Huizinga M, Hommel B (2009 a): Recreational cocaine polydrug use impairs
cognitive flexibility but not working memory. Psychopharmacology 207(2): 225 – 234.
Colzato LS, van den Wildenberg WP, Hommel B (2009 b): Reduced attentional scope in
cocaine polydrug users. PLoS One 4(6): e6043.
Cook JM, Marshall R, Masci C, Coyne JC (2007): Physicians’ perspectives on prescribing
benzodiazepines for older adults: a qualitative study. J Gen Intern Med 22(3): 303 – 307
Coper H (2000): Stimulanzien. In: Uchtenhagen A, Zieglgnsberger W (Hrsg.): Suchtmedizin. Mnchen: Urban & Fischer. S. 71 – 77.
Couve JA (2002): Towards a treatment of chronic benzodiazepine users suffering from
depression. Kumulative Dissertation Universitt Leiden.
Couve JE, Zitman FG (2002): The benzodiazepine withdrawal symptom questionnaire:
psychometric evaluation during a discontinuation program in depressed chronic benzodiazepine users in general practice. Addiction 97: 337 – 345 (auch in: Couve JA:
Towards a treatment of chronic benzodiazepine users suffering from depression. Dissertation Universitt Leiden. S. 47 – 58).
Crews FT, Collins MA, Dlugos C, Littleton J, Willkins L, Neafsey EJ, Pentney R, Snell LD,
Tabakoff B, Noronha A (2004): Alcohol-induced neurodegeneration: when, where why?
Alcohol Clin Exp Res 28: 350 – 364.
Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh EW,
Pfefferbaum A, Zou J, Sullivan EV (2005): Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res 29: 1504 – 1513.
Crews FT, He J, Hodge C (2007): Adolescent cortical development: a critical period of
vulnerability for addiction. Pharmacol Biochem Behav 86(2): 189 – 199.
Crews FT, Boettiger CA (2009): Impulsivity, frontal lobes and risk for addiction. Pharmacol
Biochem Behav 93: 237 – 247.
Crews FT, Nixon K (2003): Alcohol, neural stem cells, and adult neurogenesis. Alcohol Res
Health 27: 197 – 204.
Critchley JA, Capewell S (2003): Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290(1): 86 – 97.
Crome I, Sidhu H, Crome P (2009): No longer only a young man’s disease – illicit drugs
and older people. J Nutr Health Aging 13(2): 141 – 143.
Curtis JR, Geller G, Stokers EJ, Levine DM, Moore RD (1989): Characteristics, diagnosis,
and treatment of alcoholism in elderly patients. J AM GERIATR SOC 37: 310 – 316.
Cysique LA, Brew BJ (2009): Neuropsychological functioning and antiretroviral treatment
in HIV/AIDS: a review. Neuropsychol Rev 19(2): 169 – 185.
David SP, Munaf
MR (2008): Smoking cessation in primary care. Evidence does not
support routine use of combination therapy with nortriptyline. BMJ 336: 1200 – 1201.
Davies SJ, Pandit SA, Feeney A, Stevenson BJ, Kerwin RW, Nutt DJ, Marshall EJ, Boddington S, Lingford-Hughes A (2005): Is there cognitive impairment in clinically „healthy“ abstinent alcohol dependence? Alcohol Alcohol 40: 498 – 503.
Day E, Bentham P, Callaghan R, Kuruvilla T, George S (2009): Thiamine for WernickeKorsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev
DII: 10 1002/14 651 858.CD004 033.pub2.
Deary IJ, Pattie A, Taylor MD, Whiteman MC, Starr JM, Whalley LJ (2003): Smoking and
cognitive change from age 11 to age 80. Journal of Neurology, Neurosurgery, and Psychiatry 74: 1006 – 1007.
Degenhardt L, Lynskey M, Hall W (2000): Cohort trends in the age of initiation of drug use
in Australia. Aust N Z J Public Health 24(4): 421 – 426.
9
de las Cuevas C, Sanz EJ, de la Fuente JA et al. (2000): The severity of dependence scale
(SDS) as screening test for benzodiazepine dependence: SDS Validation study. Addiction
95: 245 – 250.
Denis C, Fatsas M, Lavie E, Auriacombe M (2006): Pharmacological interventions for
benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev Issue 3. Art. No.: CD005 194. DOI: 10 1002/14 651 858.CD005 194.pub2.
Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C, Bramson H,
Friedman SR (2007): The transition from injection to non-injection drug use: long-term
outcomes among heroin and cocaine users in New York City. Addiction 102(5):
778 – 785.
Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M (2006): A 2-year follow-up study of
alcohol consumption and risk of dementia. Clin Neurol Neurosurg 108: 378 – 383.
De Oliveira LG, Barroso LP, Silveira CM, Sanchez ZV, De Carvalho Ponce J, Vaz LJ,
Nappo SA (2009): Neuropsychological assessment of current and past crack cocaine
users. Subst Use Misuse 44(13): 1941 – 1957.
Donny EC, Houtsmuller E, Stitzer ML (2006): Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 102: 324 – 334.
Donny EC, Dierker LC (2007): The absence of DSM-IV nicotine dependence in moderateto-heavy daily smokers. Drug Alcohol Depend 89(1): 93 – 96.
Donz J, Ruffieux C, Cornuz J (2007): Determinants of smoking and cessation in older
women. Age Ageing 36(1): 53 – 57.
Doolan DM, Froelicher ES (2006): Efficacy of smoking cessation intervention among
special populations: review of the literature from 2000 to 2005. Nurs Res 55(4 Suppl):
S29–S37.
Doolan DM, Stotts NA, Benowitz NL, Covinsky KE, Froelicher ES (2008): The Women’s
Initiative for Nonsmoking (WINS) XI: age-related differences in smoking cessation
responses among women with cardiovascular disease. Am J Geriatr Cardiol 17(1):
37 – 47.
DSM-IV (1998): Diagnostisches und statistisches Manual Psychischer Stçrungen. Hogrefe:
Gçttingen. 2. Aufl.
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW (2008): A metaanalytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165(2): 179 – 187.
Dworetzky BA, Bromfield EB, Townsend MK, Kang JH (2010): A prospective study of
smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult
women: data from the Nurses’ Health Study II. Epilepsia 51(2): 198 – 205.
Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, John U, Broocks A,
Hohagen F, Rumpf HJ (2006): The reliability and validity of the Alcohol Use Disorders
Identification Test (AUDIT) in a German general practice population sample. J Stud
Alcohol 67(3): 473 – 481.
DZA – Deutsches Zentrum fr Altersfragen (2010): Deutscher Alterssurvey: Die zweite
Lebenshlfte. http://www.dza.de/nn_39284/DE/Forschung/Alterssurvey/alterssurvey_node.html?_nnn=true – Zugriff 13.09.2010.
Ebly EM, Hogan DB, Fung TS (1997): Potential Adverse Outcomes of Psychotropic and
Narcotic Drug Use in Canadian Seniors. J Clin Epidemiol 50: 857 – 863.
Edelstein SL, Kritz-Silverstein D, Barrett-Connor E (1998): Prospective association of smoking and alcohol use with cognitive function in an elderly cohort. J Womens Health
7(10): 1271 – 1281.
10
Literatur
Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M (2007): Risk factors for clinically
recognized opioid abuse and dependence among veterans using opioids for chronic noncancer pain. Pain 129(3): 355 – 362.
Egan M, Moride Y, Wolfson C, Monette J (2000): Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr
Soc 48(7): 811 – 816.
Eggers C (2000): HIV-1-assoziierte Enzephalopathie und Myelopathie. Nervenarzt 71:
677 – 684.
Eisen SA, Lyons MJ, Goldberg J, True WR (1993): The impact of cigarette and alcohol
consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs.
Arch Intern Med 153(21): 2457 – 2463.
Eisenberg D, Quinn BC (2006): Estimating the effect of smoking cessation on weight gain:
an instrumental variable approach. Health Serv Res 41(6): 2255 – 2266.
Elwert G (1994): Altern im interkulturellen Vergleich. In: Baltes PB, Mittelstraß J, Staudinger UM (Hrsg.): Alter und Altern. Ein interdisziplinrer Studientext zur Gerontologie.
Berlin: de Gruyter. S. 261 – 282.
Emsley R, Smith R, Roberts M, Kapnias S, Pieters H, Maritz S (1996): Magnetic resonance
imaging in alcoholic Korsakoff’s syndrome: evidence for an association with alcoholic
dementia. Alcohol Alcohol 31: 479 – 486.
Epstein EE, Fischer-Elber K, Al-Otaiba Z (2007): Women, aging, and alcohol use disorders.
J Women Aging 19(1 – 2): 31 – 48.
Epstein-Lubow G, Davis JD, Miller IW, Tremont G (2008): Persisting burden predicts
depressive symptoms in dementia caregivers. J Geriatr Psychiatry Neurol 21(3):
198 – 203.
Ersek M, Cherrier MM, Overman SS, Irving GA (2004): The cognitive effects of opioids.
Pain Manag Nurs 5(2): 75 – 93.
Espeland MA, Coker LH, Wallace R, Rapp SR, Resnick SM, Limacher M, Powell LH,
Messina CR; Women’s Health Initiative Study of Cognitive Aging (2006): Association
between alcohol intake and domain-specific cognitive function in older women. Neuroepidemiology 27: 1 – 12.
Estler CJ (1997): Arzneimittel im Alter. Stuttgart: Wissenschaftliche Verlagsgesellschaft.
2. Aufl.
Ettrich KU, Fischer-Cyrulies A (2004): Substanzmissbrauch im mittleren und hçheren
Erwachsenenalter – Allgemeiner Missbrauch. Z Gerontol Geriat 37: 272 – 279.
Fagerstrçm KO (2005): Raucherentwçhnung – wie effektiv kann sie sein? In: Batra A
(Hrsg.): Tabakabhngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart:
Kohlhammer. S. 93 – 96.
Fagerstrçm K, Aubin HJ (2009): Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin 25(2): 511 – 518.
Falck RS, Wang J, Carlson RG (2007): Crack cocaine trajectories among users in a midwestern American city. Addiction 102(9): 1421 – 1431.
Falck RS, Wang J, Carlson RG (2008): Among long-term crack smokers, who avoids and
who succumbs to cocaine addiction? Drug Alcohol Depend 98: 24 – 29.
Fama R, Marsh L, Sullivan EV (2004 a): Dissociation of remote and anterograde memory
impairment and neuronal correlates in alcoholic Korsakoff syndrome. J Int Neuropsychol Soc 10: 427 – 441.
Fama R, Pfefferbaum A, Sullivan EV (2004 b): Perceptual learning in detoxified alcoholic
men: contributions from explicit memory, executive function, and age. Alcohol Clin Exp
Res 28: 1657 – 1665.
11
Fama R, Pfefferbaum A, Sullivan EV (2006): Visuoperceptual learning in alcoholic Korsakoff syndrome. Alcohol Clin Exp Res 30: 680 – 687.
Fastbom J, Forsell Y, Winblad B (1998): Benzodiazepines may have protective effects
against Alzheimer disease. Alzheimer Dis Assoc Disord 12: 14 – 17.
Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ (2002):
Cortical grey matter loss in treatment-naive alcohol dependent individuals. Alcohol Clin
Exp Res 26: 558 – 564.
Fein G, Torres J, Price LJ, Di Sclafani V (2006): Cognitive performance in long-term
abstinent alcoholic individuals. Alcohol Clin Exp Res 30: 1538 – 1544.
Fengler J (1992): Helfende Berufe – Umgang mit Medikamenten und Medikamentenabhngigen. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg.): Medikamentenabhngigkeit. Freiburg: Lambertus. S. 202 – 207.
Ferguson J, Bauld L, Chesterman J, Judge K (2005): The English smoking treatment services: one-year outcomes. Addiction 100 (Suppl 2): 59 – 69.
Ferrara CM, Kumar M, Nicklas B, McCrone S, Goldberg AP (2001): Weight gain and
adipose tissue metabolism after smoking cessation in women. Int J Obes Relat Metab
Disord 25(9): 1322 – 1326.
Ferrara M, Langiano E, Di Brango T, De Vito E, Di Cioccio L, Bauco C (2008): Prevalence
of stress, anxiety and depression in with Alzheimer caregivers. Health Qual Life Outcomes 6(6): 93.
Filozof C, Fernndez Pinilla MC, Fernndez-Cruz A (2004): Smoking cessation and weight
gain. Obes Rev 5(2): 95 – 103.
Finlayson RE (1995): Misuse of Prescription Drugs. Int J Addict 30: 1871 – 1901.
Fischer T (2009): Gruppenpsychotherapie bei Abhngigkeitserkrankungen. In: Bilitza KW
(Hrsg.): Psychotherapie der Sucht. Psychoanalytische Beitrge zur Praxis. Gçttingen:
Vandenhoeck & Ruprecht. 2. Aufl. S. 111 – 131.
Fishbain DA (2003): Chronic opioid treatment, addiction and pseudo-addiction in patients
with chronic pain. Psychiatric Times, Vol XX, Issue 2.
Fishbain DA, Rosomoff HL, Rosomoff RS (1992): Drug abuse, dependence, and addiction
in chronic pain patients. Clin J Pain 8: 77 – 85.
Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM (1995): The influence of
smoking cessation on the prevalence of overweight in the United States. N Engl J Med
333(18): 1165 – 1170.
Fleischhacker WW (1995): Unerwnschte Wirkungen, Kontraindikationen, berdosierungen, Intoxikation. In: Riederer P, Laux G, Pçldinger W (Hrsg): Neuro-Psycho-Pharmaka.
Bd. 2: Tranquilizer und Hypnotika. Wien: Springer. S. 84 – 89.
Fleischhacker WW, Barnas C, Hinterhuber H (1987): Benzodiazepin-Verordnungen an
einer Universittsklinik. Nervenarzt 58: 754 – 758.
Fleming MF, Manwell LB, Barry KL, Adams W, Stauffacher EA (1999): Brief physician
advice for alcohol problems in older adults: a randomized community-based trial. J Fam
Pract 48(5): 378 – 384.
Fçrstl H (Hrsg.) (2003): Lehrbuch der Gerontopsychiatrie- und -psychotherapie. Stuttgart:
Thieme. 2. Aufl.
Fçrstl H (2006): Kognitive Stçrungen: Koma, Delir, Demenz. In: Fçrstl H, Hautzinger M,
Roth G (Hrsg.): Neurobiologie psychischer Stçrungen. Heidelberg: Springer.
S. 221 – 295.
Foy A, O’Connell D, Henry D, Kelly J, Cocking S, Halliday J (1995): Benzodiazepine Use
as a Cause of Cognitive Impairment in Elderly Hospital Inpatients. J Gerontol A Biol Sci
Med Sci 50: M99 – 106.
12
Literatur
Frank C (2010): „Ordentlich Pegel“ Viele rzte sind schtig nach Tabletten, Alkohol und
Nikotin – eine besondere Therapieform hilft den kranken Helfern. Sddeutsche Zeitung
12. 01. 2010.
Franklin KBJ (1998): Analgesia and abuse potential: an accidental association or a common
substrate? Pharmacology Biochemistry and Behavior 59: 993 – 1002.
Frei A (1996): Benzodiazepine – unntz und schdlich? (Rez. von „Benzodiazepin-Dependence“, ed. by Halstroem C, Oxford 1993). Psychiat Prax 23: 155 – 156.
Freye E (2010): Opioide in der Medizin. Heidelberg: Springer. 8. Aufl.
Freye E, Levy J (2000): Acute abstinence syndrome following abrupt cessation of long-term
use of tramadol (Ultram): a case study. Eur J Pain 4(3): 307 – 311.
Freye E, Latasch L (2003): Toleranzentwicklung unter Opioidgabe – Molekulare Mechanismen und klinische Bedeutung. Ansthesiol Intensivmed Notfallmed Schmerzther
38(1): 14 – 26.
Fritze J (2009): Versorgungsgerechtigkeit in der Lebensspanne. Nervenarzt 80(11):
1283 – 1292.
Froom P, Melamed S, Benbassat J (1998): Smoking cessation and weight gain. J Fam Pract
46(6): 460 – 464.
Grtner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Ostgathe C, Elsner F,
Sabatowski R (2006): Assessing cognition and psychomotor function under long-term
treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 50(6): 664 – 672.
Gallop RJ, Crits-Christoph P, Ten Have TR, Barber JP, Frank A, Griffin ML, Thase ME
(2007): Differential transitions between cocaine use and abstinence for men and women.
J Consult Clin Psychol 75(1): 95 – 103.
Ganguli M, van der Bilt J, Saxton JA, Shen C, Dodge HH (2005): Alcohol consumption and
cognitive function in late life: a longitudinal community study. Neurology 65:
1210 – 1217.
Geiselmann B (1992): Langzeittherapie mit Psychopharmaka versus Arzneimittelabhngigkeit. In: Helmchen H, Linden M (Hrsg.): Die jahrelange Behandlung mit Psychopharmaka. Berlin, New York: de Gruyter. S. 185 – 201.
Gfroerer JC, Epstein JF (1999): Marijuana initiates and their impact on future drug abuse
treatment need. Drug Alcohol Depend 54(3): 229 – 237.
Gfroerer JC, Penne M, Pemberton M, Folsom R (2003): Substance abuse treatment need
among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol
Depend 69(2): 127 – 135.
Gilg T (2005): Rechtsmedizinische Aspekte von Alkohol und Alkoholismus. In: Singer MV,
Teyssen S (Hrsg.): Alkohol und Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl.
S. 551 – 576.
Glaeske G (1991): Arzneimittelverbrauch von Menschen im hçheren Lebensalter unter
besonderer Bercksichtigung von Arzneimitteln mit Abhngigkeitspotential. Dsseldorf:
Ministerium fr Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen.
Glassman AH, Covey LS, Stetner F, Rivelli S (2001): Smoking cessation and the course of
major depression: a follow-up study. Lancet 357(9272): 1929 – 1932.
Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M (2002): Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19 732 men and women from The
Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 156(11):
994 – 1001.
Godtfredsen NS, Osler M, Vestbo J, Andersen I, Prescott E (2003): Smoking reduction,
smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Den-
13
mark 1976 – 1998: a pooled cohort study. J Epidemiol Community Health 57(6):
412 – 416.
Godtfredsen NS, Prescott E, Osler M (2005): Effect of smoking reduction on lung cancer
risk. JAMA 294(12): 1505 – 1510.
Golub A, Johnson BD, Dunlap E, Sifaneck S (2004): Projecting and Monitoring the Life
Course of the Marijuana/Blunts Generation. J Drug Issues 34(2): 361 – 388.
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J,
Williams KE, Reeves KR; Varenicline Phase 3 Study Group (2006): Varenicline, an
alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296(1):
47 – 55.
Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den
Hoogen HJ, Mulder J, Breteler MH, Zitman FG (2005): Discontinuation of long-term
benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend 78 (1): 49 – 56.
Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, Breteler MH,
van den Hoogen HJ, Mulder J, Zitman FG (2006): Predictors of discontinuation of
benzodiazepine prescription after sending a letter to long-term benzodiazepine users in
family practice. Fam Pract 23 (1): 65 – 72.
Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, Mulder J, van den Hoogen H,
van Balkom AJ, Breteler MH, Zitman FG (2007): Consequences of a benzodiazepine
discontinuation programme in family practice on psychotropic medication prescription
to the participants. Fam Pract 24(5): 504 – 510.
Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L (2006): Benzodiazepine
discontinuation among adults with GAD: A randomized trial of cognitive-behavioral
therapy. J Consult Clin Psychol 74 (5): 908 – 919.
Grad R, Tamblyn R, Holbrook AM, Hurley J, Feightner J, Grayton D (1999): Risk of New
Benzodiazepine Presription in Relation to Recent Hospitalization. J Am Geriatr Soc 47:
184 – 188.
Grßel E (1998): Husliche Pflege dementiell und nicht dementiell Erkrankter. Z Gerontol
Geriat 31: 57 – 62.
Greenblatt DJ, Harmatz JS, Shader RI (1991 a): Clinical Pharmacokinetics of Anxiolytics
and Hypnotics in the Elderly. Therapeutic Considerations (Part I). Clin Pharmacokinet
21: 165 – 177.
Greenblatt DJ, Harmatz JS, Shader RI (1991 b): Clinical Pharmacokinetics of Anxiolytics
and Hypnotics in the Elderly. Therapeutic Considerations (Part II). Clin Pharmacokinet
21: 262 – 273.
Grohmann R, Poser W, Schmidt LG, Wolf B (1991): Medikamenten-Missbrauch und -Abhngigkeit bei psychiatrischen Patienten. Ergebnisse der AMP-Studie. In: Hippius H,
Ortner M, Rther E (Hrsg.): Psychiatrische Erkrankungen in der rztlichen Praxis. Berlin: Springer. S. 21 – 25.
Gruber SA, Silveri MM, Yurgelun-Todd DA (2007): Neuropsychological consequences of
opiate use. Neuropsychol Rev 17(3): 299 – 315.
Grndel L (1999): Therapie von Schlafstçrungen. In: Platt D, Mutschler E (Hrsg.): Pharmakotherapie im Alter. Stuttgart: Wissenschaftliche Verlagsgesellschaft. S. 332 – 355.
Gupta S, Warner J (2008): Alcohol-related dementia: a 21st-century silent epidemic? Br J
Psychiatry 193: 351 – 353.
Gutzmann H, Zank S (2005): Demenzielle Erkrankungen. Medizinische und psychosoziale
Interventionen. Stuttgart: Kohlhammer.
14
Literatur
Haasen C, Prinzleve M, Gossop M, Fischer G, Casas M (2005): Relationship between
cocaine use and mental health problems in a sample of European cocaine powder or
crack users. World Psychiatry 4(3): 173 – 176.
Hach I, Rentsch A, Krappweis J, Kirch W (2004): Psychopharmakaverordnungen an lteren Menschen. Z Gerontol Geriat 37: 214 – 220.
Hhnchen A, Gastpar M (1999): Kokain. In: Gastpar M, Mann K, Rommelspacher H
Hajak G, Mller WE, Wittchen HU, Pittrow D, Kirch W (2003): Abuse and dependence
potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case
reports and epidemiological data. Addiction 98: 1371 – 1378.
Hajek P, Stead LF, West R, Jarvis M, Lancaster T (2009): Relapse prevention interventions
for smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No.: CD003 999. DOI:
10 1002/14 651 858.CD003 999.pub3.
Hall RC, Zisook S (1981): Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol
11 (Suppl 1): S99–S104.
Hall SM (2007): Nicotine interventions with comorbid populations. Am J Prev Med
33(6 Suppl): S406–S413.
Hall SM, Tunstall CD, Vila KL, Duffy J (1992): Weight gain prevention and smoking
cessation: cautionary findings. Am J Public Health 82(6): 799 – 803.
Hall SM, Humfleet GL, Gorecki JA, MuÇoz RF, Reus VI, Prochaska JJ (2008): Older versus
younger treatment-seeking smokers: differences in smoking behavior, drug and alcohol
use, and psychosocial and physical functioning. Nicotine Tob Res 10(3): 463 – 470.
Hallhauer J, Bienstein C, Lehr U, Rçnsch H (2005): SVIP – Studie zur rztlichen Versorgung in Pflegeheimen. Hannover: Vincentz.
Hamburgische Landesstelle gegen die Suchtgefahren (Hrsg.) (1989): Abhngigkeit im Alter.
Mçglichkeiten und Grenzen der Hilfe. Hamburg: Eigenverlag.
Hamburgische Landesstelle gegen die Suchtgefahren (Hrsg.) (1990): Alter und Sucht. Hamburg: Eigenverlag.
Hamilton AB, Grella CE (2009): Gender differences among older heroin users. J Women
Aging 21(2): 111 – 124.
Hanlon CA, Wesley MJ, Roth AJ, Miller MD, Porrino LJ (2010): Loss of laterality in
chronic cocaine users: an fMRI investigation of sensorimotor control. Psychiatry Res
181(1): 15 – 23.
Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE Jr, Landerman
LR, Pieper CF, Blazer DG, Cohen HJ (1998): Benzodiazepine use and cognitive function
among community-dwelling elderly. Clin Pharmacol Ther 64(6): 684 – 692.
Harper C (2006): Thiamine (vitain B 1) deficiency and associated brain damage is still
common throughout the world and prevention is simple and safe! European Journal of
Neurology 13: 1078 – 1082.
Harper CG, Sheedy DL, Lara AI, Garrick TM, Hilton JM, Raisanen J (1998): Prevalence of
Wernicke-Korsakoff syndrome in Australia: has thiamine fortification made a difference?
Med J Aust 168(11): 542 – 545.
Harris CR, Albaugh B, Goldman D, Enoch MA (2003): Neurocognitive impairment due to
alcohol consumption in an American Indian community. J Stud Alcohol 64: 458 – 466.
Harrison M, Busto U, Naranjo CA, Kaplan HL, Sellers EM (1984): Diazepam tapering in
detoxification for high-dose benzodiazepine abuse. Clin Pharmacol Ther 36(4):
527 – 533.
Hart CL, Morrison DS, Batty GD, Mitchell RJ, Smith GD (2010): Effect of body mass
index and alcohol consumption on liver disease: analysis of data from two prospective
cohort studies. BMJ 2010;340:c1240. DOI: 10 1136/bmj.c1240.
15
Harvey JA (2004): Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 27(8): 751 – 764.
Haug H (1994): Morphologische Vernderungen des Zentralnervensystems. In: Olbrich E,
Sames K, Schramm A (Hrsg.): Kompendium der Gerontologie. Landsberg: Ecomed.
IV-5.9.1.1.
Haustein KO, Groneberg D (2008): Tabakabhngigkeit. Berlin: Springer.
Hautzinger M (2000): Depression im Alter. Ein Therapieprogramm fr ltere depressive
Menschen. Weinheim: Psychologie Verlags Union.
Havemann-Reinecke U, v Raison F (1998): Kçnnen Alterungsprozesse bzw. degenerative
Prozesse Sucht beeinflussen? In: Havemann-Reinecke U, Weyerer S, Fleischmann H
(Hrsg.): Alkohol und Medikamente, Missbrauch und Abhngigkeit im Alter. Freiburg:
Lambertus. S. 106 – 116.
Haw C, Stubbs J, Yorston G (2008): Antipsychotics for BPSD: an audit of prescribing
practice in a specialist psychiatric inpatient unit. Int Psychogeriatr 20(4): 790 – 799.
Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ (2003): Marked
disparity between age-related changes in dopamine and other presynaptic dopaminergic
markers in human striatum. J Neurochem 87(3): 574 – 585.
He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A (2007): Interaction of thiamine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultrastructure. Neuropsychopharmacology 32(10): 2207 – 2216.
Heap LC, Pratt OE, Ward RJ, Waller S, Thomson AD, Shaw GK, Peters TJ (2002): Individual susceptibility to Wernicke-Korsakoff syndrome and alcoholism-induced cognitive
deficit: impaired thiamine utilization found in alcoholics and alcohol abusers. Psychiatr
Genet 12(4): 217 – 224.
Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J, Giddings D (2004):
Randomised controlled trial of two brief interventions against long-term benzodiazepine
use: outcome of intervention. Addict Res Theory 12: 141 – 154.
Heigl-Evers A, Helas I, Vollmer HC (1995): Suchtkranke in ihrer inneren und ußeren
Realitt. Praxis der Suchttherapie im Methodenvergleich. Gçttingen: Vandenhoeck &
Ruprecht.
Heigl-Evers A, Helas I, Vollmer HC (1997): Die Person des Therapeuten in der Behandlung
Suchtkranker. Gçttingen: Vandenhoeck & Ruprecht.
Helmchen H, Baltes MM, Geiselmann B, Kanowski S, Linden M, Reischies FM, Wagner
M, Wilms HU (1996): Psychische Erkrankungen im Alter. In: Mayer KU, Baltes PB
(Hrsg.): Die Berliner Altersstudie. Berlin. Akademie Verlag. S. 185 – 220.
Helmchen H, Kanowski S (2001): Gerontopsychiatrie in Deutschland. Gegenwrtige Entwicklung und zuknftige Anforderungen. In: Deutsches Zentrum fr Altersfragen
(Hrsg.): Gerontopsychiatrie und Alterspsychotherapie in Deutschland. Expertisen zum
Dritten Altenbericht der Bundesregierung, Bd. 4. Opladen: Leske + Buderich. S. 11 – 111.
Helmchen H, Kanowski S, Lauter H (2006): Ethik in der Altersmedizin. Stuttgart: Kohlhammer.
Helzer JE, Burnam A, McEvoy LT (1991): Alcohol Abuse and Dependence. In: Robins LN,
Regier DA (Eds.): Psychiatric Disorders in America: The Epidemiological Catchment
Area Study. New York: the Free Press. S. 81 – 115.
Hendricks PS, Prochaska JJ, Humfleet GL, Hall SM (2008): Evaluating the validities of
different DSM-IV-based conceptual constructs of tobacco dependence. Addiction 103(7):
1215 – 1223.
Herbeck DM, Hser YI, Lu AT, Stark ME, Paredes A (2006): A 12-year follow-up study of
psychiatric symptomatology among cocaine-dependent men. Addict Behav 31(11):
1974 – 1987.
16
Literatur
Herbert LE, Scherr PA, Beckett LA, Albert MS, Rosner B, Taylor JO, Evans DA (1993):
Relation of smoking and low-to-moderate alcohol consumption to change in cognitive
function: a longitudinal study in a defined community of older persons. Am J Epidemiol
137(8): 881 – 891.
Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT; ITINERE Investigators (2008):
Psychiatric comorbidity in young cocaine users: induced versus independent disorders.
Addiction 103(2): 284 – 293.
Heuft G (2009): Der kçrperliche Alternsprozess als Organisator der Entwicklung in der
zweiten Hlfte des Erwachsenenalters. rztliche Psychotherapie 4(1): 5 – 9.
Higgins ST, Budney AJ, Bickel WK, Badger GJ (1994): Participation of significant others in
outpatient behavioral treatment predicts greater cocaine abstinence. Am J Drug Alcohol
Abuse 20(1): 47 – 56.
Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL (2000): Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.
J Consult Clin Psychol 68(1): 64 – 72.
Higgitt A, Lader HM, Fonagy P (1985): Clinical Management of Benzodiazepine Dependence. Br Med J 291: 688 – 690.
Hirshman E, Fisher J, Henthorn T, Arndt J, Passannante A (2003): Midazolam amnesia and
retrieval from semantic memory: Developing methods to test theories of implicit memory. Brain Cogn 53(3): 427 – 432.
Ho SC, Chan A, Woo J, Chong P, Sham A (2009): Impact of caregiving on health and
quality of life: a comparative population-based study of caregivers for elderly persons
and noncaregivers. J Gerontol A Biol Sci Med Sci 64(8): 873 – 879.
Hoffmann E, Schelhase T, Menning S (2009): Lebenserwartung und Sterbegeschehen. In:
Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge
zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des
Statistischen Bundesamtes, des Deutschen Zentrums fr Altersfragen und des RobertKoch-Instituts (RKI). Berlin: RKI. S. 92 – 104.
Hoffmann F, Glaeske G, Scharffetter W (2006): Zunehmender Hypnotikaverbrauch auf
Privatrezepten in Deutschland. Sucht 52: 360 – 366.
Hoffmann F, Scharffetter W, Glaeske G (2009): Verbrauch von Zolpidem und Zopiclon auf
Privatrezepten zwischen 1993 und 2007. Nervenarzt 52: 578 – 583.
Hoffmann NG, Olofsson O, Salen B, Wickstrom L (1995): Prevalence of abuse and dependency in chronic pain patients. Int J Addict 30: 919 – 927.
Hogan DB, Maxwell CJ, Fung TS, Ebly EM; Canadian Study of Health and Aging (2003):
Prevalence and potential consequences of benzodiazepine use in senior citizens: results
from the Canadian Study of Health and Aging. Can J Clin Pharmacol 10(2): 72 – 77.
Homewood J, Bond NW (1999): Thiamin deficiency and Korsakoff’s syndrome: failure to
find memory impairments following nonalcoholic Wernicke’s encephalopathy. Alcohol
19: 75 – 84.
Howard AA, Klein RS, Schoenbaum EE (2003): Association of hepatitis C infection and
antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 36(10):
1318 – 1323.
Howes JB, Ryan J, Fairbrother G, O’Neill K, Howes LG (1996): Benzodiazepine prescribing in a Sydney teaching hospital. Med J Aust 165: 305 – 308.
Hser YI, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R (2006): A 12-year
follow-up of a treated cocaine-dependent sample. J Subst Abuse Treat 30(3): 219 – 226.
Hser YI, Huang D, Brecht ML, Li L, Evans E (2008): Contrasting trajectories of heroin,
cocaine, and methamphetamine use. J Addict Dis 27(3): 13 – 21.
17
Hudmon KS, Kilfoy BA, Prokhorov AV (2006): The epidemiology of tobacco use and
dependence. Crit Care Nurs Clin North Am 18(1): 1 – 11.
Hughes JR, Keely J, Naud S (2004): Shape of the relapse curve and long-term abstinence
among untreated smokers. Addiction 99(1): 29 – 38.
Hughes JR, Adams EH, Franzon MA, Maguire MK, Guary J (2005): A prospective study of
off-label use of, abuse of, and dependence on nicotine inhaler. Tob Control 14: 49 – 54.
Hughes JR, Kalman D (2006): Do smokers with alcohol problems have more difficulty
quitting? Drug Alcohol Depend 82(2): 91 – 102.
Hughes JR, Stead LF, Lancaster T (2007): Antidepressants for smoking cessation. Cochrane
Database Syst Rev Issue 1. Art. No.: CD000 031. DOI: 101002/14651858.CD000031.pub3.
Huntgeburth E (2010): persçnl. Mitteilung.
Husemoen LL, Osler M, Godtfredsen NS, Prescott E (2004): Smoking and subsequent risk
of early retirement due to permanent disability. Eur J Public Health 14(1): 86 – 92.
Husten CG, Shelton DM, Chrismon JH, Lin YC, Mowery P, Powell FA (1997): Cigarette
smoking and smoking cessation among older adults: United States, 1965 – 1994. Tob
Control 6(3): 175 – 180.
Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD (1997):
Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob
Control 6 (Suppl 2): S57–S62.
Ibach B (2009): Polypharmazie in der Gerontopsychiatrie. In: Messer T, Schmauss M
(Hrsg.): Polypharmazie in der Behandlung psychischer Erkrankungen. Heidelberg: Springer. S. 144 – 177.
Iga JI, Araki M, Ishimoto Y, Ohmori T (2001): A case of Korsakoff’s syndrome improved
by high doses of donepezil. Alcohol Alcohol 36: 553 – 555.
Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods B (2004): Attitudes to
long-term use of benzodiazepine hypnotics by older people in general practice: findings
from interviews with service users and providers. Aging & Mental Health 8: 242 – 248.
Iuvone T, Esposito G, De Filippis D, Scuderi C, Steardo L (2009): Cannabidiol: a promising
drug for neurodegenerative disorders? CNS Neurosci Ther 15(1): 65 – 75.
Izaute M, Paire-Ficout L, Bacon E (2004): Benzodiazepines and semantic memory: effects
of lorazepam on the Moses illusion. Psychopharmacology 172(3): 309 – 315.
Izaute M, Bacon E (2005): Effects of the amnesic drug lorazepam on complete and partial
information retrieval and monitoring accuracy. Psychopharmacology 188(4): 472 – 481.
Jacobi J (2005): Anti-Aging: Sinnbild, Sehnsucht, Wirklichkeit. In: Jacobi et al. (Hrsg.):
Kursbuch Anti-Aging. Stuttgart: Thieme. S. 2 – 13.
Jacobsen LK, Picciotto MR, Heath CJ, Frost SJ, Tsou KA, Dwan RA, Jackowski MP,
Constable RT, Mencl WE (2007): Prenatal and adolescent exposure to tobacco smoke
modulates the development of white matter microstructure. J Neurosci 27(49):
13 491 – 13 498.
Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF (2006): Long-term effects of
frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology 185(3): 358 – 368.
Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003): Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage
26(4): 913 – 921.
Jncke L (2004): Neuropsychologie des Alterns. In: Kruse A, Martin M (Hrsg.): Enzyklopdie der Gerontologie. Bern: Huber. S. 207 – 223.
Jarvenpaa T, Rinne JO, Koskenvuo M, Raiha I, Kaprio J (2005): Binge drinking in midlife
and dementia risk. Epidemiology 16: 766 – 771.
18
Literatur
Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC,
Palmer BW, Patterson TL, Reynolds CF 3rd, Lebowitz BD (1999): Consensus statement
on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades.
Arch Gen Psychiatry 56(9): 848 – 853.
Jha SH, Knapp CM, Kornetsky C (2004): Effects of morphine on brain-stimulation reward
thresholds in young and aged rats. Pharmacol Biochem Behav 79(3): 483 – 490.
Johansson BA, Berglund M, Lindgren A (2006): Efficacy of maintenance treatment with
naltrexone for opioid dependence: a meta-analytical review. Addiction 101(4): 491 – 503.
Johansson BA, Berglund M, Lindgren A (2007): Efficacy of maintenance treatment with
methadone for opioid dependence: a meta-analytical study. Nord J Psychiatry 61(4):
288 – 295.
John U, Meyer C, Rumpf HJ, Hapke U (2004 a): Depressive disorders are related to nicotine dependence in the population but do not necessarily hamper smoking cessation.
J Clin Psychiatry 65(2): 169 – 176.
John U, Meyer C, Rumpf HJ, Hapke U (2004 b): Smoking, nicotine dependence and psychiatric comorbidity – a population-based study including smoking cessation after three
years. Drug Alcohol Depend 76(3): 287 – 295.
John U, Hanke M, Rumpf HJ, Thyrian JR (2005): Smoking status, cigarettes per day, and
their relationship to overweight and obesity among former and current smokers in a
national adult general population sample. Int J Obes 29(10): 1289 – 1294.
John U, Meyer C, Rumpf HJ, Hapke U, Schumann A (2006): Predictors of increased body
mass index following cessation of smoking. Am J Addict 15(2): 192 – 197.
Johnell K, Fastbom J (2009): The use of benzodiazepines and related drugs amongst older
people in Sweden: associated factors and concomitant use of other psychotropics. Int J
Geriatr Psychiatry 24(7): 731 – 738.
Johnson KH, Bazargan M, Cherpitel CJ (2001): Alcohol, tobacco, and drug use and the
onset of type 2 diabetes among inner-city minority patients. J Am Board Fam Pract 14(6):
430 – 436.
Joseph H, Stancliff S, Langrod J (2000): Methadone maintenance treatment (MMT): a
review of historical and clinical issues. Mt Sinai J Med 67(5 – 6): 347 – 364.
Joyce EM (1994): Aetiology of alcoholic brain damage: alcoholic neurotoxicity or thiamine
malnutrition? Br Med Bull 50: 99 – 114.
Kamboj SK, Curran HV (2006): Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine. Psychopharmacology 188(4): 482 – 488.
Kan CC, Breteler MHM, Timmermans EAY, van der Ven AHGS, Zitman FG (1999):
Scalability, Reliability, and Validity of the Benzodiazepine Dependence Self-Report Questionnaire in Outpatient Benzodiazepine Users. Compr Psychiatry 40(4): 283 – 291.
Kan CC, Breteler MH, van der Ven AH, Zitman FG (2001 a): Cross-validation of the
benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users.
Compr Psychiatry 42(5): 433 – 439.
Kan CC, an der Ven AH, Breteler MH, Zitman FG (2001 b): Latent Trait Standardization
of the Benzodiazepine Dependence Self-Report Questionnaire Using the Rasch Scaling
Model. Compr Psychiatry 42(5): 424 – 432.
Kan CC, Zitman FG, Breteler MHM (2001 c): Multidimension Assessment of Benzodiazepine Dependence. Vortrag APA Conference New Orleans 8 – 5-2001. http://cckan.ruhosting.nl/KanBdepAPA.pdf Zugriff 08. 01. 2010
Karkos J (1991): Neurotoxizitt von Benzodiazepinen. Fortschr Neurol Psychiat 59:
498 – 520.
19
Kasahara H, Krasawa A, Ariyasu T, Thukahara T, Satou J, Ushijima S (1996): Alcohol
Dementia and Alcohol Delirium in Aged Alcoholics. Psychiatr Clin Neurosci 50:
115 – 123.
Kato N (1991): Clinical concept of alcoholic dementia. Arukoru Kenkyuto Yakubutsu Ison
26: 119 – 133.
Kato N (1996): A case with primary alcoholic dementia – an investigation of dementia
associated with alcoholism. Jpn J Psychiatry Res Alcohol 5: 15 – 24.
Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C,
Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R (2007):
Challenges in the development of prescription opioid abuse-deterrent formulations.
Clin J Pain 23(8): 648 – 660.
Kaul M (2009): HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 22(3): 315 – 320.
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Hunter DJ,
Hennekens CH, Speizer FE (1993): Smoking cessation in relation to total mortality rates
in women. A prospective cohort study. Ann Intern Med 119(10): 992 – 1000.
Kempermann G (2007): Nicht ausgeliefert an Zeit und Welt. Die Plastizitt des alternden
Gehirns. In: Gruss P (Hrsg.): Die Zukunft des Alterns. Mnchen: Beck. S. 35 – 50.
Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. (2008): Smoking and smoking cessation in relation to mortality in women. JAMA 299(17): 2037 – 2047.
Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM (2007): Pharmacotherapy of dual
substance abuse and dependence. CNS Drugs 21(3): 213 – 237.
Kenney BA, Holahan CJ, Holahan CK, Brennan PL, Schutte KK, Moos RH (2009): Depressive symptoms, drinking problems, and smoking cessation in older smokers. Addict
Behav 34(6 – 7): 548 – 553.
Kiefer F, Grosshans M (2009): Beitrag der Suchtforschung zum Verstndnis der Adipositas.
Nervenarzt 80(9): 1040 – 1049.
Kim KY, Ke V, Adkins LM (2004): Donepezil for alcohol-related dementia: a case report.
Pharmacotherapy 24: 419 – 412.
Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA (1999 a): Benzodiazepine
use among the elderly in the community. Int J Geriatr Psychiatry 14: 280 – 284.
Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA (1999 b): Influence of
symptoms of anxiety on treatment of depression in later life in primary care: questionnaire survey. BMJ 318: 379 – 380.
Kirchen-Peters S (2008): Gerontopsychiatrischer Konsiliar- und Liaisondienst – Pioniere
warten auf Nachahmer. Zeitschrift fr Gerontologie und Geriatrie 41: 467 – 474.
Kirchner JE, Zubritsky C, Cody M, Coakley E, Chen H, Ware JH, Oslin DW, Sanchez HA,
Durai UN, Miles KM, Llorente MD, Costantino G, Levkoff S (2007): Alcohol consumption among older adults in primary care. J Gen Intern Med 22(1): 92 – 97.
Kissel EC, Pukay-Martin ND, Bornstein RA (2005): The relationship between age and
cognitive function in HIV-infected men. J Neuropsychiatry Clin Neurosci 17(2):
180 – 184.
Klotz U (1986): Klinische Pharmakologie der Benzodiazepine. In: Hippius H, Engel RR,
Laakmann G (Hrsg.): Benzodiazepine. Rckblick und Ausblick. Berlin: Springer.
S. 32 – 39.
Klotz U (1995): Benzodiazepin-Tranquilizer – Pharmakokinetik. In: Riederer P, Laux G,
Pçldinger W (Hrsg.): Neuro-Psycho-Pharmaka. Bd. 2: Tranquilizer und Hypnotika.
Wien: Springer. S. 13 – 23.
20
Literatur
Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA (2006): Incidence and causes
of nondegenerative nonvascular dementia: a population-based study. Arch Neurol 63:
218 – 221.
Kochsiek K (2009): Eckpunkte fr Empfehlungen der gemeinsamen Arbeitsgruppe „Chancen und Probleme einer alternden Gesellschaft“ der Deutschen Akademie der Naturforscher Leopoldina und der Deutschen Akademie fr Technikwissenschaften acatech.
In: Kochsiek K (Hrsg.): Altern und Gesundheit. (Altern in Deutschland Band 7). Nova
Acta Leopoldina NF 105, Nr. 369: 53 – 58. Halle (Saale): Deutsche Akademie der Naturforscher Leopoldina/Stuttgart: Wissenschaftliche Verlagsgesellschaft.
Kolitzus H (1997): Die Liebe und der Suff . . . Schicksalsgemeinschaft Suchtfamilie. Mnchen: Kçsel.
Kçrkel J, Kruse G (1997): Mit dem Rckfall leben. Bonn: Psychiatrie-Verlag, 3. Aufl.
Kçrkel J, Veltrup C (2003): Motivational Interviewing. Eine bersicht. Suchttherapie 4:
115 – 124.
Kouimtsidis C, Padhi A (2007): A case of late-onset dependence on cocaine and crack.
Addiction 102(4): 666 – 667.
Kouyanou K, Pither CE, Wessely S (1997): Medication misuse, abuse and dependence in
chronic pain patients. J Psychosom Res 43: 497 – 504.
Kraemer KL, Mayo-Smith MF, Calkins DR (1997): Impact of age on the severity, course,
and complications of alcohol withdrawal. Arch Intern Med 157(19): 2234 – 2241.
Kraus L, Semmler C, Hose A, Kunz-Ebrecht S, Hffer I, Orth B (2004): Epidemiologie,
Prvention und Therapie von Kokainkonsum und kokainbezogenen Stçrungen – eine
Literaturbersicht. IFT-Berichte Bd. 144. Mnchen: Institut fr Therapieforschung (IFT).
Kraus L, Augustin R, Kunz-Ebrecht S, Orth B (2007): Drug use patterns and drug-related
disorders of cocaine users in a sample of the general population in Germany. Eur Addict
Res 13(2): 116 – 125.
Kraus L, Pfeiffer-Gerschel T, Pabst A (2008): Cannabis und andere illegale Drogen –
Prvalenz, Konsummuster und Trends. Ergebnisse des epidemiologischen Suchtsurveys
2006. Sucht 54 (Sonderheft 1): S16–S25.
Krausz M, Lambert M (2000): Cannabis. In: Uchtenhagen A, Zieglgnsberger W (Hrsg.):
Suchtmedizin. Mnchen: Urban & Fischer. S. 77 – 82.
Krishnan S, Cairns R, Howard R (2009): Cannabinoids for the treatment of dementia.
Cochrane Database Syst Rev 15(2): CD007 204.
Kriston L, Hçlzel L, Weiser AK, Berner MM, Hrter M (2008): Meta-analysis: Are 3 Questions Enough to Detect Unhealthy Alcohol Use? Ann Intern Med 149(12): 879 – 888.
Krçger C (2005): Die Psychologie des Rauchens – Grundlage fr eine psychologische
Behandlung. In: Batra A (Hrsg.): Tabakabhngigkeit. Wissenschaftliche Grundlagen
und Behandlung. Stuttgart: Kohlhammer. S. 83 – 92.
Kroll LE, Ziese T (2009): Kompression oder Expansion der Morbiditt? In: Bçhm K,
Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge zur
Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums fr Altersfragen und des Robert-KochInstituts (RKI). Berlin: RKI. S. 105 – 112.
Kruse A (2002): Gesund altern. Stand der Prvention und Entwicklung ergnzender Prventionsstrategien. Schriftenreihe des Bundesministeriums fr Gesundheit, Bd. 146.
Baden-Baden: Nomos.
Kudoh A, Takase H, Takahira Y, Takazawa T (2004): Postoperative confusion increases in
elderly long-term benzodiazepine users. Anesth Analg 99(6): 1674 – 1678.
Klpmann WR (2008): Vergiftungen und Drogenabusus. In: Thomas L (Hrsg.): Labor und
Diagnose. Frankfurt/M.: TH-Books Verlagsgesellschaft. S. 1569 – 1584.
21
Knig G, Dtwyler S, Eschen A, Schreiter-Gasser U (2006): Unrecognised long-lasting
tramadol-induced delirium in two elderly patients. A case report. Pharmacopsychiatry
39(5): 194 – 199.
Kunze C (2009): Das Elend des Alters. Hellenistische Genreskulpturen von Fischern, Landleuten und alten Frauen. In: Landschaftsverband Rheinland, LVR LandesMuseum Bonn
(Hrsg.): Alter in der Antike. Die Blte des Alters aber ist die Weisheit. Mainz: von
Zabern. S. 107 – 123.
Ladewig D (1990): Tranquilizer: Problematik von Mißbrauch und Abhngigkeit. In: Herz
A, Hippius H, Spann W (Hrsg.): Psychopharmaka heute. Berlin: Springer. S. 140 – 149.
Ladewig D (1992): Abusus und Abhngigkeit. In: Riederer P, Laux G, Pçldinger W (Hrsg.):
Neuro-Psycho-Pharmaka. Bd. 1: Allgemeine Grundlagen der Pharmakopsychiatrie.
Wien: Springer. S. 411 – 423.
Lampert T (2009): Soziale Ungleichheit und Gesundheit im hçheren Lebensalter. In: Bçhm
K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge zur
Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums fr Altersfragen und des Robert-KochInstituts (RKI). Berlin: RKI. 212 – 133.
Lampert T, List SM (2009): Tabak – Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle fr Suchtgefahren (DHS) (Hrsg.): Jahrbuch Sucht 2009. Geesthacht: Neuland.
S. 51 – 71.
Lancaster T, Hajek P, Stead LF, West R, Jarvis MJ (2006): Prevention of relapse after
quitting smoking: a systematic review of trials. Arch Intern Med 166(8): 828 – 835.
Landkreis Esslingen (Hrsg.) (1992): Sucht im Alter. Verleugnet – geduldet – verordnet.
3. Fachtagung Gerontopsychiatrie 01.–02. 04. 1992. Esslingen: Eigenverlag.
Lang I, Wallace RB, Huppert FA, Melzer D (2007): Moderate alcohol consumption in older
adults is associated with better cognition and well-being than abstinence. Age Ageing
36(3): 2562 – 2561.
Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ (2001): The impact of
harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health 91(5): 774 – 780.
Launer LJ, Feskens EJ, Kalmijn S, Kromhout D (1996): Smoking, drinking, and thinking.
The Zutphen Elderly Study. Am J Epidemiol 143(3): 219 – 227.
Laurijssens BE, Greenblatt DJ (1996): Pharmacokinetic-Pharmacodynamic Relationships
for Benzodiazepines. Clin Pharmacokinet 30: 52 – 76.
Lauterbach W (2002): Großelternschaft und Mehrgenerationenfamilien – soziale Realitt
oder demographischer Mythos? Z Gerontol Geriat 35: 540 – 555.
Laux G (1995 a): Aktueller Stand der Behandlung mit Benzodiazepinen. Nervenarzt 66:
311 – 322.
Laux G, Kçnig W (1986): Benzodiazepin-Abusus. Epidemiologische und klinisch-klassifikatorische Aspekte. In: Heimann H, Gaertner HJ (Hrsg.): Das Verhltnis der Psychiatrie
zu ihren Nachbardisziplinen. Berlin: Springer. S. 262 – 272.
Lee HS, Mericle AA, Ayalon L, Aren PA (2009): Harm reduction among at-risk elderly
drinkers: a site-specific analysis from the multi-site Primary Care Research in Substance
Abuse and Mental Health for Elderly (PRISM-E) study. Int J Geriatr Psychiatry 24(1):
54 – 60.
Leesemann S (1995): Suchtkrankheiten bei rztinnen und rzten. Berufsstress und hohe
Drogenakzeptanz. Dt rztebl 92(47): A-3300–A-3305.
Legnaro A (2000): Rausch und Sucht in der Sozial- und Kulturgeschichte Europas. In:
Uchtenhagen A, Zieglgnsberger W (Hrsg.): Suchtmedizin. Mnchen: Urban & Fischer.
S. 8 – 21.
22
Literatur
Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL,
Leonard DGB, Shields PG, Epstein LH (2004): Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology 174: 571 – 577.
Letenneur L (2004): Risk of dementia and alcohol and wine consumption: a review of
recent results. Biol Res 37: 189 – 193.
Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994):
Psychoactive Medications and Injurious Vehicle Collisions Involving Older Drivers. Epidemiology 5: 591 – 598.
Levens S, Dyer AM, Zubritsky C, Knott K, Oslin DW (2005): Gambling among older,
primary-care patients: an important public health concern. Am J Geriatr Psychiatry
13(1): 69 – 76.
Lexikon der Neurowissenschaften. (2000) Stichwort „Altern“. Bd. 1. Heidelberg: Spektrum Akademischer Verlag.
Liberto JG, Oslin DW (1995): Early Versus Late Onset of Alcoholism in the Elderly. Int
J Addict 30: 1799 – 1818.
Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002): Reduced frontal white matter
integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51(11): 890 – 895.
Lim KO, Wozniak JR, Mueller BA, Franc DT, Specker SM, Rodriguez CP, Silverman AB,
Rotrosen JP (2008): Brain macrostructural and microstructural abnormalities in cocaine
dependence. Drug Alcohol Depend 92(1 – 3): 164 – 172.
Lindemann RD, Wayne SJ, Baumgartner RN, Garry PJ (2005): Cognitive function in
drinkers compared to abstainers in the New Mexico elder health survey. J Gerontol A
Biol Sci Med Sci 60: 1065 – 1070.
Linden M, Bohlken J (1992): Compliance und Psychopharmakotherapie. In: Riederer P,
Laux G, Pçldinger W (Hrsg.): Neuro-Psycho-Pharmaka. Bd. 1: Allgemeine Grundlagen
der Pharmakopsychiatrie. Wien, New York: Springer. S. 201 – 209.
Linden M, Br T, Geiselmann B (1998): Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med 28: 721 – 729.
Lindinger P (2005): Die Motivation des Rauchers zur Abstinenz. In: Batra A (Hrsg.):
Tabakabhngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart: Kohlhammer. S. 115 – 131.
Ling PM, Glantz SA (2004): Tobacco industry research on smoking cessation. Recapturing
young adults and other recent quitters. J Gen Intern Med 19(5 Pt 1): 419 – 426.
Lissner L, Bengtsson C, Lapidus L, Bjçrkelund C (1992): Smoking initiation and cessation
in relation to body fat distribution based on data from a study of Swedish women. Am
J Public Health 82(2): 273 – 275.
Liu B, Reeves G, Beral V, on behalf of the Million Women Study Collaborators (2010):
Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study.
BMJ 2010;340:c912. DOI: 10 1136/bmj.c912.
Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE (1995): Falls Among Older People:
Relationship to Medication Use and Orthostatic Hypotension. J Am Geriatr Soc 43:
1141 – 1145.
Liu H, Li L, Hao Y, Cao D, Xu L, Rohrbaugh R, Xue Z, Hao W, Shan B, Liu Z (2008):
Disrupted white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor imaging. Am J Drug Alcohol Abuse 34(5): 562 – 575.
Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG, Old Age Task Force of the
World Federation of Biological Psychiatry (2005): Systematic review of psychological
approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 162: 1996 – 2021.
23
Lçvheim H, Sandman PO, Kallin K, Karlsson S, Gustafson Y (2006): Relationship between
antipsychotic drug use and behavioral and psychological symptoms of dementia in old
people with cognitive impairment living in geriatric care. Int Psychogeriatr 18(4):
713 – 726.
Lçvheim H, Karlsson S, Gustafson Y (2008 a): The use of central nervous system drugs and
analgesics among very old people with and without dementia. Pharmacoepidemiol Drug
Saf 17(9): 912 – 918.
Lçvheim H, Sandman PO, Kallin K, Karlsson S, Gustafson Y (2008 b): Symptoms of mental
health and psychotropic drug use among old people in geriatric care, changes between
1982 and 2000. Int J Geriatr Psychiatry 23(3): 289 – 294.
Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R (2004): Alcohol intake and risk of
dementia. JAGS 52: 540 – 546.
Lddens H, Wiedemann K (2008): Anxiolytika und Hypnotika. In Holsboer F, Grnder G,
Benkert O (Hrsg.): Handbuch der Psychopharmakotherapie. Berlin: Springer.
S. 591 – 626
Luderer HJ (1986): Suchtgefahren im Alter. Nervenheilkunde 5: 195 – 198.
Luderer HJ, Schulz M, Mayer M (1995): Langzeiteinnahme von Benzodiazepinen – Krankheitsentwicklung, Folgeerscheinungen, Behandlung. Psychiat Prax 22: 231 – 234.
Lundqvist T (2005): Cognitive consequences of cannabis use: comparison with abuse of
stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81(2): 319 – 330.
Ltzelschwab J (2009): Haus Harmonie. Ein Pilotprojekt fr ltere Drogenabhngige in
Basel Land. Vortrag bei der Fachtagung „ltere Drogenabhngige – Versorgungskonzepte an der Schnittstelle zwischen Sucht- und Altenhilfe“ am 22. 10. 2009 in Mnchen.
http://www.paritaet-bayern.de/webcode/link.php?id=954 – Zugriff 30. 04. 2010.
Lyvers M, Yakimoff M (2003): Neuropsychological correlates of opioid dependence and
withdrawal. Addict Behav 28(3): 605 – 611.
Maercker A (Hrsg.) (2002): Alterspsychotherapie und klinische Gerontopsychologie. Berlin: Springer.
Mahoney R, Regan C, Katona C, Livingston G (2005): Anxiety and depression in family
caregivers of people with Alzheimer disease: the LASER-AD study. Am J Geriatr 13(9):
795 – 801.
Maier W, Franke P, Linz M (1999): Mehrfachdiagnosen (Komorbiditt). In: Gastpar M,
Mann K, Rommelspacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme.
S. 183 – 201.
Mancuso CE, Tanzi MG, Gabay M (2004): Paradoxical reactions to benzodiazepines:
literature review and treatment options. Pharmacotherapy 24(9): 1177 – 1185.
Mann K, Rommelspacher H (1999): Alkohol. In: Gastpar M, Mann K, Rommelspacher H
Mann K, Diehl A, Hein J, Heinz A (2009 a): Alkoholabhngigkeit. In: Vorderholzer U,
Hohagen F (Hrsg.): Therapie psychischer Stçrungen. State of the Art 2008/2009. Mnchen, Urban & Fischer. 4. Aufl. S. 23 – 38.
Manzardo AM, Penick EC (2006): A theoretical argument for inherited thiamine insensitivity as one possible biological cause of familial alcoholism. Alcohol Clin Exp Res 30(9):
1545 – 1550.
Mardorf S, Bçhm K (2009): Bedeutung der demografischen Alterung fr das Ausgabengeschehen im Gesundheitswesen. In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge zur Gesundheitsberichterstattung des Bundes. Eine
gemeinsame Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums
fr Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 247 – 266.
24
Literatur
Marlow SP, Stoller JK (2003): Smoking cessation. Respir Care 48(12): 1238 – 1254.
Marteau T, Ashcroft R, Oliver A (2009): Using financial incentives to achieve healthy
behaviour. BMJ 338: 983 – 985.
Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR (2009):
Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained
Patients. A Randomized, Double-blind, Placebo-Controlled Efficacy Trial. Arch Gen
Psychiatry 66(10): 1116 – 1123.
Martin J, Matthews A, Martin F, Kirkby KC, Alexander J, Daniels B (2002): Effects of
lorazepam and oxazepam on perceptual and procedural memory functions. Psychopharmacology 164(3): 262 – 267.
Martin PR, Adinoff B, Eckardt MJ, Stapleton JM, Bone GA, Rubinow DR, Lane E, Linnoila M (1989): Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings. Arch Gen Psychiatry 46: 617 – 621.
Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingartner H, Linnoila M,
Eckardt MJ (1995): Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuropsychopharmacol 5: 27 – 33.
Martin PR, Singleton CK, Hiller-Sturmhofel S (2003): The role of thiamine deficiency in
alcoholic brain disease. Alcohol Res Health 27: 134 – 142.
Martn-Snchez E, Furukawa TA, Taylor J, Martin JL (2009): Systematic review and metaanalysis of cannabis treatment for chronic pain. Pain Med 10(8): 1353 – 1368.
Masica AL, Girard TD, Wilkinson GR, Thomason JW, Truman Pun B, Nair UB, Light RW,
Canonico AE, Dunn J, Pandharipande P, Shintani AK, Ely EW (2007): Clinical sedation
scores as indicators of sedative and analgesic drug exposure in intensive care unit
patients. Am J Geriatr Pharmacother 5(3): 218 – 213.
Mulen B (1992): Abhngigkeit in Pflegeberufen. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg.): Medikamentenabhngigkeit. Freiburg: Lambertus. S. 217 – 223.
Mulen B (1993): Sucht in helfenden Berufen. Abhngigkeitserkrankungen bei Krankenpflegekrften und rzten. Psychiat Prax 20 (Sonderheft 1): 42 – 45.
Maurage P, Pesenti M, Philippot P, Joassin F, Campanella S (2009): Latent deleterious
effects of binge drinking over a short period of time revealed only by electrophysiological
measures. J Psychiatry Neurosci 34(2): 111 – 118.
McFall M, Saxon AJ, Thompson CE, Yoshimoto D, Malte C, Straits-Troster K, Kanter E,
Zhou XH, Dougherty CM, Steele B. (2005): Improving the rates of quitting smoking for
veterans with posttraumatic stress disorder. Am J Psychiatry 162(7): 1311 – 1319.
McGregor C, Machin A, White JM (2003): In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods. Drug Alcohol Rev 22(2):
175 – 180.
McGuire LC, Ajani UA, Ford ES (2007): Cognitive functioning in late life: the impact of
moderate alcohol consumption. Ann Epidemiol 17(2): 93 – 99.
McIntosh C, Kippen V, Hutcheson F, McIntosh A (2005): Parenteral thiamine use in the
prevention and treatment of Wernicke-Korsakoff syndrome. Psychiatric Bulletin 29:
94 – 97.
McKee SA, Harrison EL, O’Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR,
Petrakis IL, Estevez N, Balchunas E (2009): Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 66(2): 185 – 190.
McKibbin CL, Ancoli-Israel S, Dimsdale J, Archuleta C, von Kanel R, Mills P, Patterson
TL, Grant I (2005): Sleep in spousal caregivers of people with Alzheimer’s disease. Sleep
28(10): 1245 – 1250.
25
Melchinger H, Schnabel R, Wyns B (1992): Verordnungpraxis von Medikamenten mit
Abhngigkeitspotential. Schriftenreihe des Bundesministeriums fr Gesundheit, Bd. 13.
Baden-Baden: Nomos.
Mendelson WB (1992): Clinical Distinctions between Long-Acting and Short-Acting Benzodiazepines. J Clin Psychiatry 53(Suppl): 4 – 7.
Mendelson WB (1996): The Use of Sedative/Hypnotic Medication and its Correlation With
Falling Down in Hospital. Sleep 19: 698 – 701.
Mendelson WB, Thompson C, Franko T (1996): Adverse Reactions to Sedative/Hypnotics:
Three Years’ Experience. Sleep 19: 702 – 706.
Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, Besser M (2004): The
effects of transdermal fentanyl on driving, cognitive performance, and balance in patients
with chronic nonmalignant pain conditions. Pain Med 5(1): 42 – 49.
Menninger JA (2002): Assessment and treatment of alcoholism and substance-related disorders in the elderly. Bull Menninger Clin 66(2): 166 – 183.
Merfert-Diete C (2009): Daten, Zahlen und Fakten. In: Deutsche Hauptstelle fr Suchtgefahren (DHS) (Hrsg.): Jahrbuch Sucht 2009. Geesthacht: Neuland. S. 7 – 20.
Merritt P, Hirshman E, Hsu J, Berrigan M (2005): Metamemory without the memory: are
people aware of midazolam-induced amnesia? Psychopharmacology 177(3): 336 – 343.
Merritt P, Hirshman E, Zamani S, Hsu J, Berrigan M (2006): Episodic representations
support early semantic learning: evidence from midazolam induced amnesia. Brain
Cogn 61(2): 219 – 223.
Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP (2008): Smoking cessation rates in the
United States: a comparison of young adult and older smokers. Am J Public Health
98(2): 317 – 322.
Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamson
RN (2004): Predicting aberrant drug behavior in patients treatment for chronic pain:
impoartance of abuse history. J Pain Symptom Manage 28: 250 – 258.
Mimura M, Komatsu S, Kato M, Yoshimasu H, Moriyama Y, Kashima H (2005): Further
evidence for a comparable memory advantage of self-performed tasks in Korsakoff’s
syndrome and nonamnesic control subjects. J Int Neuropsychol Soc 11(5): 545 – 553.
Mineur YS, Picciotto MR (2008): Genetics of nicotinic acetylcholine receptors: Relevance
to nicotine addiction. Biochem Pharmacol 75(1): 323 – 333.
Mintzer MZ, Correia CJ, Strain EC (2004): A dose-effect study of repeated administration
of buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alcohol Depend 74(2): 20 520 – 20 529.
Mintzer MZ, Griffiths RR (2005): Drugs, memory, and metamemory: a dose-effect study
with lorazepam and scopolamine. Exp Clin Psychopharmacol 13(4): 336 – 347.
Mintzer MZ, Griffiths RR (2007): Differential effects of scopolamine and lorazepam on
working memory maintenance versus manipulation processes. Cogn Affect Behav Neurosci 7(2): 12 012 – 12 019.
Mizoue T, Ueda R, Tokui N, Hino Y, Yoshimura T (1998): Body mass decrease after initial
gain following smoking cessation. Int J Epidemiol 27(6): 984 – 988.
Moffoot A, O’Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM (1994):
Clondine infusion increases uptake of 99mTc-Exametazimein anterior cingulate cortex
in Korsakoff’s psychosis. Psychol Med 24: 53 – 61.
Mol AJJ, Oude Voshaar RC, Gorgels WJMJ, Breteler MHM, van Balkom AJLM, van de
Lisdonk EH, van der Ven AHGS, Zitman FG (2003): Development and psychometric
evaluation of the Benzodiazepine Craving Questionnaire. Addiction 98: 1143 – 1152.
Molter-Bock E, Hasford J, Pfundstein T (2006): Psychopharmakologische Behandlungspraxis in Mnchener Altenpflegeheimen. Z Gerontol Geriat 39: 336 – 343.
26
Literatur
Molyneux GJ, McCarthy GM, McEniff S, Cryan M, Conroy RM (2008): Prevalence and
predictors of carer burden and depression in carers of patients referred to an old age
psychiatric service. Int Psychogeriatr 20(6): 1193 – 1202.
Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J (2009):
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebocontrolled trial. Drug Alcohol Depend 101(1 – 2): 34 – 41.
Moore AA, Seeman T, Morgenstern H, Beck JC, Reuben DB (2002): Are there differences
between older persons who screen positive on the CAGE questionnaire and the Short
Michigan Alcoholism Screening Test – Geriatric Version? J Am Geriatr Soc 50(5):
858 – 862.
Moos RH, Schutte K, Brennan P, Moos BS (2004): Ten-year patterns of alcohol consumptionand drinking problems among older women and men. Addiction 99: 829 – 838.
Moos RH, Brennan PL, Schutte KK, Moos BS (2005): Older adults’ health and changes in
late-life drinking patterns. Aging Ment Health 9(1): 49 – 59.
Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallires A (2004): Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate
benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry
161(2): 332 – 342.
Morin CM, Blanger L, Bastien C, Vallires A (2005): Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther
43 (1): 1 – 14.
Moriyama Y, Muramatsu T, Kato M, Kashima H (2004): Repeated clinical episodes of
Wernicke-Korsakoff syndrome. Aust N Z J Psychiatry 38: 653.
Mrazek M, Menges C, Steffes J, Thelen B, Erkwoh R (1999): Therapeutische Erfahrungen
beim alkoholbedingten Korsakow-Syndrom. Nervenarzt 70: 790 – 794.
Mukamal KJ, Ascherio A, Mittleman MA, Conigrave KM, Camargo CA jr., Kawachi I,
Stampfer MJ, Willett WC, Rimm EB (2005): Alcohol and risk for ischemic stroke in men:
the role of drinking patterns and usual beverage. Ann Intern Med 142: 11 – 19.
Mller WE (1992): Klinische Pharmakologie von Psychopharmaka im hçheren Lebensalter.
In: Hfner H, Hennerici M (Hrsg.): Psychische Krankheiten und Hirnfunktion im Alter.
Stuttgart: Fischer. S. 171 – 185.
Mller WE (1995): Benzodiazepin-Tranquilizer. In: Riederer P, Laux G, Pçldinger W
(Hrsg.): Neuro-Psycho-Pharmaka. Bd. 2: Tranquilizer und Hypnotika. Wien: Springer.
S. 23 – 41.
Mller R, Zilker T (2009): Medikamenten-, Drogen- und Alkoholabhngigkeit. In: Fçrstl
H (Hrsg.): Demenzen in Theorie und Praxis. Heidelberg: Springer. 2. Aufl. S. 171 – 191.
Munaf
MR, Tilling K, Ben-Shlomo Y (2009): Smoking status and body mass index: a
longitudinal study. Nicotine Tob Res 11(6): 765 – 771.
Mundle G (2000): Geriatrische Patienten. In: Zernig G, Saria A, Kurz M, O’Malley SS
(Hrsg.): Handbuch Alkoholismus. Universittsklinik fr Psychiatrie Innsbruck.
S. 163 – 176.
Munro CA, Saxton J, Butters MA (2001): Alcohol dementia: „cortical“ or „subcortical“
dementia? Arch Clin Neuropsychol 16: 523 – 533.
Najavits LM, Lester KM (2008): Gender differences in cocaine dependence. Drug Alcohol
Depend 97(1 – 2): 190 – 194.
Nakao M, Takeuchi T, Nomura K, Teramoto T, Yano E (2006): Clinical application of
paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting
an internal medicine clinic. Psychiatry Clin Neurosci 60(5): 605 – 610.
Neutel CI (1995): Risk of Traffic Accident Injury after a Prescription for a Benzodiazepine.
Ann Epidemiol 5: 239 – 244.
27
Neutel CI, Hirdes JP, Maxwell CJ, Patten SB (1996): New Evidence on Benzodiazepine Use
and Falls: the Time Factor. Age Ageing 25: 273 – 278.
Ngandu T, Helkala EL, Soininen H, Winblad B, Tuomilehto J, Nissinen A, Kivipelto M
(2007): Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk
Factors Aging and Dementia (CAIDE) Study. Dement Geriatr Cogn Disord 23(3):
140 – 149.
Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR (2006):
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial
agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial
with 1-year follow-up. Arch Intern Med 166(15): 1561 – 1568.
Niejahr E (2007): Altersarmut. Die Zeit 3. 9. 2007. http://www.zeit.de/2007/36/Altersarmut – Zugriff 30. 04. 2010.
Niveau G, Rougemont AL, La Harpe R (2002): Methadone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983 – 1999. Eur J Public
Health 12(3): 224 – 227.
Nixon K (2006): Alcohol and adult neurogenesis: roles in neurodegenration and recovery in
chronic alcoholism. Hippocampus 16: 287 – 295.
Nogueira AM, Pompia S, Galdurz JC, Bueno OF (2006): Effects of a benzodiazepine on
free recall of semantically related words. Hum Psychopharmacol 21(5): 327 – 336.
Nordstrom BL, Kinnunen T, Utman CH, Garvey AJ (1999): Long-term effects of nicotine
gum on weight gain after smoking cessation. Nicotine Tob Res 1(3): 259 – 268.
Norris KC, Thornhill-Joynes M, Robinson C, Strickland T, Alperson BL, Witana SC, Ward
HJ (2001): Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis
38(3): 523 – 528.
Nçthen M, Bçhm K (2009): Krankheitskosten in Deutschland: Welchen Preis hat die
Gesundheit im Alter? In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und
Krankheit im Alter. Beitrge zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums fr
Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 228 – 246.
Nystrçm C (2005): Effects of long-term benzodiazepine medication. A prospective cohort
study: methodological and clinical aspects. Nord J Psychiatry 59(6): 492 – 497.
Oberwittler C (2006): Vitaminstoffwechselerkrankungen. In: Gnnewig T, Erbguth F
(Hrsg.): Praktische Neurogeriatrie. Stuttgart: Kohlhammer. S. 386 – 398.
O’Carroll RE, Moffoot A, Ebmeier K, Goodwin GM (1994): Effects of fluvoxamine
treatment on cognitive functioning in the alcoholic Korsakoff syndrome. Psychopharmacology 116: 85 – 88.
O’Hara P, Connett JE, Lee WW, Nides M, Murray R, Wise R (1998): Early and late weight
gain following smoking cessation in the Lung Health Study. Am J Epidemiol 148(9):
821 – 830.
Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K
(2006): Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial
agonist, varenicline, for smoking cessation. Arch Intern Med 166(15): 1571 – 1577.
Opitz K (2000): Tabakabhngigkeit. Hilfen zum Entzug. In: Uchtenhagen A, Zieglgnsberger W (Hrsg.): Suchtmedizin. Mnchen: Urban & Fischer. S. 53 – 63.
Oscar-Berman M, Kirkley SM, Gansler DA, Couture A (2004): Comparisons of Korsakoff
and non-Korsakoff alcoholics on neuropsychological tests of prefrontal brain functioning. Alcohol Clin Exp Res 28: 667 – 675.
Oslin D, Liberto JG, O’Brien J, Krois S, Norbeck J (1997): Naltrexone as an adjunctive
treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 5(4):
324 – 332.
28
Literatur
Oslin DW, Slaymaker VJ, Blow FC, Owen PL, Colleran C (2005): Treatment outcomes for
alcohol dependence among middle-aged and older adults. Addict Behav 30(7):
1431 – 1436.
Oslin DW, Grantham S, Coakley E, Maxwell J, Miles K, Ware J, Blow FC, Krahn DD,
Bartels SJ, Zubritsky C, Olsen E, Kirchner JE, Levkoff S (2006): PRISM-E: comparison
of integrated care and enhanced specialty referral in managing at-risk alcohol use. Psychiatr Serv 57(7): 954 – 958.
Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, KraghSorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ; EURODEM
Incidence Research Group (2004): Effect of smoking on global cognitive function in
nondemented elderly. Neurology 62(6): 920 – 924.
Oude Voshaar RC, Mol AJJ, Gorgels WJMJ, Breteler MHM, van Balkom AJLM, van de
Lisdonk EH, Kann CC, Zitman FG (2003 c): Cross-Validation, Predictive Validity, and
Time Course of the Benzodiazepine Dependence Self-Report Questionnaire in a Benzodiazepine Discontinuation Trial. Compr Psychiatry 44(3): 247 – 255.
Oude Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH,
Breteler MH, Zitman FG (2006 b): Predictors of long-term benzodiazepine abstinence in
participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatry 51 (7): 445 – 452.
Oude Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH,
Breteler MH, Zitman FG (2006 c): Long-term outcome of two forms of randomised
benzodiazepine discontinuation. Br J Psychiatry 188: 188 – 189.
Oulis P, Konstantakopoulos G, Kouzoupis AV, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kontoangelos KA, Papadimitriou GN (2008 a): Pregabalin in the discontinuation
of long-term benzodiazepines’ use. Hum Psychopharmacol 23(4): 337 – 340.
Oulis P, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kouzoupis AV, Konstantakopoulos G, Soldatos CR (2008 b): Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series. Int Clin Psychopharmacol 23(2): 110 – 112.
Owen-Smith V, Hannaford PC (1999): Stopping smoking and body weight in women living
in the United Kingdom. Br J Gen Pract 49(449): 989 – 990.
Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, Stickgold R (2008):
Cocaine users differ from normals on cognitive tasks which show poorer performance
during drug abstinence. Am J Drug Alcohol Abuse 34(1): 109 – 121.
Pakesch G, Katschnig H, Dittrich R, Loimer N, Rasinger E, Tutsch G. (1993): Prvalenz
und soziodemographische Korrelate des Benzodiazepingebrauchs in einer Großstadtbevçlkerung. Nervenarzt 64: 312 – 317.
Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF (2007): The role of nicotinic
acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects
of nicotine. Neuropsychopharmacology 32(5): 1098 – 1108.
Parkin T (2005): Das antike Griechenland und die rçmische Welt. Das Alter – Segen oder
Fluch? In: Thane P (Hrsg.): Das Alter. Eine Kulturgeschichte. Darmstadt: Primus/WBG.
S. 31 – 70.
Parsons A, Aveyard P (2009): What is transtheoretical therapy? A response to Prochaska.
Social Science & Medicine 68: 407 – 409.
Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P (2009): Interventions for preventing
weight gain after smoking cessation. Cochrane Database Syst Rev Issue
1. Art.No.:CD006 219. DOI: 10 1002/14 651 858.CD006 219.pub2.
Parsons A, Daley A, Begh R, Aveyard P (2010): Influence of smoking cessation after
diagnosis of early stage lung cancer on prognosis: systemativ review of abservational
studies with meta-analysis. BMJ 340:b5569. DOI: 10 1136/bmj.b5569.
29
Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E (2010): Methylphenidat – Therapieoption
bei ADHS und Suchterkrankung im Erwachsenenalter? Nervenarzt 81(3): 277 – 288.
Paterniti S, Dufouil C, Alprovitch A (2002): Long-term benzodiazepine use and cognitive
decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol
22: 285 – 293.
Patkar AA, Vergare MJ, Batra V, Weinstein SP, Leone FT (2003): Tobacco smoking: current
concepts in etiology and treatment. Psychiatry 66(3): 183 – 199.
Patterson TL, Jeste DV (1999): The potential impact of the baby-boom generation on
substance abuse among elderly persons. Psychiatr Serv 50(9): 1184 – 1188.
Perkins KA (1993): Weight gain following smoking cessation. J Consult Clin Psychol 61(5):
768 – 777.
Perneger TV, Klag MJ, Whelton PK (2001): Recreational drug use: a neglected risk factor
for end-stage renal disease. Am J Kidney Dis 38(1): 49 – 56.
Peter H, Penzel T, Peter JH (2007): Enzyklopdie der Schlafmedizin. Heidelberg: Springer.
Peters M (2006): Psychosoziale Beratung und Psychotherapie im Alter. Gçttingen: Vandenhoeck & Ruprecht.
Peters M, Kipp J (Hrsg.) (2002): Zwischen Abschied und Neubeginn. Entwicklungskrisen
im Alter. Gießen: Psychosozial.
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000): Smoking, smoking cessation,
and lung cancer in the UK since 1950: combination of national statistics with two casecontrol studies. BMJ 321(7257): 323 – 329.
Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M
(1999): A programme for short-term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry
14 (9): 754 – 760.
Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M (2002): Fast withdrawal
from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial. Eur J Clin Pharmacol 57 (11): 759 – 764.
Pfefferbaum A, Sullivan EV (2005): Disruption of white matter microstructure by excessive
intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging. Neuropsychopharmacology 30: 423 – 432.
Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006 a): Supratentorial profile of white
microstructurell integritiy in recovering alcoholic men and women. Biol Psychiatry 59:
364 – 372.
Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006 b): Dysmorphology and microstructural
degradation of the corpus callosum: interaction of age and alcoholism. Neurobiol Aging
27: 994 – 1009.
Philipp M, Buller R (1986): Klassifikatorische Probleme von Mißbrauch und kçrperlicher
Abhngigkeit bei Benzodiazepinen. In: Hippius H, Engel RR, Laakmann G (Hrsg.):
Benzodiazepine. Rckblick und Ausblick. Berlin: Springer. S. 234 – 241.
Piasecki TM, McCarthy DE, Fiore MC, Baker TB (2008): Alcohol consumption, smoking
urge, and the reinforcing effects of cigarettes: an ecological study. Psychol Addict Behav
22(2): 230 – 239.
Picciotto MR, Addy NA, Mineur YS, Brunzell DH (2008): It is not „either/or“: activation
and desensitization of nicotinic acetylcholine receptors both contribute to behaviors
related to nicotine addiction and mood. Prog Neurobiol 84(4): 329 – 342.
Pierucci-Lagha A, Derouesne C (2003): Alcoholism and aging. 2. Alcoholic dementia or
alcoholic cognitive impairment? Psychol Neuropsychiatr Vieil 1: 237 – 249.
Pinquart M, Sçrensen S (2003): Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging 18(2): 250 – 267.
30
Literatur
Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB
(2008): Assessing dimensions of nicotine dependence: an evaluation of the Nicotine
Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res 10(6): 1009 – 1020.
Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB (2009): A
Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies. Arch Gen Psychiatry 66(11): 1253 – 1262.
Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M (2006): Impaired
decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug
Alcohol Depend 83(2): 163 – 168.
Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H (1992):
Smoking cessation in women concerned about weight. Am J Public Health 82(9):
1238 – 1243.
Pisani MA, Murphy TE, Van Ness PH, Araujo KL, Inouye SK (2007): Characteristics
associated with delirium in older patients in a medical intensive care unit. Arch Intern
Med 167(15): 1629 – 1634.
Pisinger C, Jorgensen T (2007): Weight concerns and smoking in a general population: the
Inter99 study. Prev Med 44(4): 283 – 289.
Poling J, Kosten TR, Sofuoglu M (2007): Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse 33(2): 191 – 206.
Pollmcher T, Wetter TC (2008): Schlafstçrungen. In: Holsboer F, Grnder G, Benkert O
(Hrsg.): Handbuch der Psychopharmakotherapie. Heidelberg: Springer. S. 977 – 993.
Pomara N, Facelle TM, Roth AE, Willoughby LM, Greenblatt DJ, Sidtis JJ (2006): Dosedependent retrograde facilitation of verbal memory in healthy elderly after acute oral
lorazepam administration. Psychopharmacology 185(4): 4874 – 4894.
Pompia S, Lucchesi LM, Bueno OF, Manzano GM, Tufik S (2004): Zolpidem and memory: a study using the process-dissociation procedure. Psychopharmacology 174(3):
327 – 333.
Pope CA III, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ (2009): Cardiovascular Mortality and Exposure to Airborne Fine Particulate Matter and Cigarette
Smoke. Shape of the Exposure-Response Relationship. Circulation 120: 941 – 948.
Poser W (1987): Klinik der Medikamentenabhngigkeit. In: Kisker KP, Lauter H, Meyer
JE, Mller C, Strçmgren E (Hrsg.): Psychiatrie der Gegenwart, Bd. 3: Abhngigkeit und
Sucht. Berlin: Springer. 3. Aufl. S. 401 – 424.
Poser W et al. (1985): Pharmakologische und klinische Daten zum Problem der Benzodiazepinabhngigkeit. In: Hippius H (Hrsg.): Buspiron-Workshop. Neue Entwicklungen der
Pharmakotherapie der Angst. Grfelfing: Edition Materia Medica.
Poser W, Poser S, Piesiur-Strehlow B, Eva P (1986): Entzugssyndrome, Abhngigkeitsrisiko
und Intoxikation mit Benzodiazepinen. In: Borchard U, Haring C (Hrsg.): Nutzen und
Gefahren der Therapie mit Benzodiazepinen. Darmstadt: Steinkopff. S. 33 – 39.
Poser W, Eva-Condemarin P (1991): Entzugssymptome nach abruptem Absetzen langfristig
eingenommener Antidepressiva: Rebound-Symptomatik? Abhngigkeit? In: Hippius H,
Ortner M, Rther E (Hrsg.): Psychiatrische Erkrankungen in der rztlichen Praxis. Berlin: Springer. S. 12 – 16.
Poser W, Poser S (1996): Medikamente – Missbrauch und Abhngigkeit. Stuttgart: Thieme.
Pçtschke-Langer M, Schulze A, Klein R (2005): Zusatzstoffe in Tabakprodukten – neue
Erkenntnisse oder altes Wissen? In: Batra A (Hrsg.): Tabakabhngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart: Kohlhammer. S. 64 – 80.
Power C, Boiss L, Rourke S, Gill MJ (2009): NeuroAIDS: an evolving epidemic. Can
J Neurol Sci 36(3): 285 – 295.
31
Preiser G (1982): Wein im Urteil der griechischen Antike. In: Vçlger G, von Welck K
(Hrsg.): Rausch und Realitt. Drogen im Kulturvergleich. Band 2. Reinbek: Rohwolt.
S. 507 – 529.
Preti A (2007): New developments in the pharmacotherapy of cocaine abuse. Addict Biol
12(2): 133 – 151.
Preuss UW, Soyka M (1997): Das Wernicke-Korsakow-Syndrom: Klinik, Pathophysiologie
und therapeutische Anstze. Fortschr Neurol Psychiat 65: 413 – 420.
Preuss UW, Soyka M (2000): Die Behandlung von alkoholbedingten hirnorganischen Psychosyndromen – Pharmakotherapeutische und psychotherapeutische Anstze. In:
Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G, Wchtler C (Hrsg.):
Angst – Sucht – Anpassungsstçrungen im Alter. Schriftenreihe der Deutschen Gesellschaft
fr Gerontopsychiatrie und -psychotherapie, Bd. 1. Stuttgart: Kohlhammer. S. 294 – 300.
Prigerson HG, Desai RA, Rosenheck RA (2001): Older adult patients with both psychiatric
and substance abuse disorders: prevalence and health service use. Psychiatr Q 72(1):
1 – 18.
Prochaska JJ, Gill P, Hall SM (2004): Treatment of tobacco use in an inpatient psychiatric
setting. Psychiatr Serv 55(11): 1265 – 1270.
Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, Rosen AB, Meisner
M, Humfleet GL, Gorecki JA (2008): Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public
Health 98(3): 446 – 448.
Prochaska JO (2009): Flaws in the theory or flaws in the study: A commentary on „The
effect of Transtheoretical Model based interventions on smoking cessation“. Social Science & Medicine 68: 404 – 406.
Prochaska JO, DiClemente CC (1992): Stages of change in the modification of problem
behaviors. Prog Behav Modif 28: 183 – 218.
Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II (2006): Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 84(3): 240 – 247.
Psychiatrie-EnquÞte (1975): Bericht ber die Lage der Psychiatrie in der Bundesrepublik
Deutschland. – Zur psychiatrischen und psychotherapeutisch/psychosomatischen Versorgung der Bevçlkerung (Drucksache 7/4200). Bonn: Deutscher Bundestag.
Quevillon F, Bdard MA (2003): Benzodiazpines: consequnces sur le fonctionnement
mnsique des personnes gees. Sante Ment Que 28(2): 23 – 41.
Radebold H (1997): Psychoanalyse und Altern. Zwei einander Fremde beginnen den Dialog. In: Ders. (Hrsg.): Altern und Psychoanalyse. Gçttingen: Vandenhoeck & Ruprecht.
S. 5 – 20.
Radebold H (Hrsg.) (2003): Kindheiten im II. Weltkrieg und ihre Folgen. Gießen: Psychosozial.
Radebold H, Schweizer R (1996): Der mhselige Aufbruch. ber Psychoanalyse im Alter.
Frankfurt/M.: Fischer.
Radebold H, Heuft G, Fooken I (Hrsg.) (2006): Kindheiten im Zweiten Weltkrieg. Kriegserfahrungen und deren Folgen aus psychohistorischer Perspektive. Mnchen: Juventa.
Rajaratnam R, Sivesind D, Todman M, Roane D, Seewald R (2009): The aging methadone
maintenance patient: treatment adjustment, long-term success, and quality of life.
J Opioid Manag 5(1): 27 – 37.
Rapeli P, Kivisaari R, Autti T, Khkçnen S, Puuskari V, Jokela O, Kalska H (2006):
Cognitive function during early abstinence from opioid dependence: a comparison to
age, gender, and verbal intelligence matched controls. BMC Psychiatry 24(6): 9.
32
Literatur
Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H (2007): Methadone vs.
buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin Pharmacol
12(7): 5.
Rsky E, Stronegger WJ, Freidl W (1996): The relationship between body weight and
patterns of smoking in women and men. Int J Epidemiol 25(6): 1208 – 1212.
Rathod NH, Addenbrooke WM, Rosenbach AF (2005): Heroin dependence in an English
town: 33-year follow-up. Br J Psychiatry 187: 421 – 425.
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987): Psychotropic Drug Use
and the Risk of Hip Fracture. N Engl J Med 316: 363 – 369.
Ray WA, Griffin MR, Downey W (1989): Benzodiazepines of Long and Short Elimination
and the Risk of Hip Fracture. JAMA 262: 3303 – 3307.
Raz N, Nagel IE (2007): Der Einfluss des Hirnalterungsprozesses auf die Kognition: Eine
Integration struktureller und funktioneller Forschungsergebnisse. In: Brandtstdter J,
Lindenberger U (Hrsg.): Entwicklungspsychologie der Lebensspanne. Stuttgart: Kohlhammer. S. 97 – 129.
Reboussin BA, Anthony JC (2006): Is there epidemiological evidence to support the idea
that a cocaine dependence syndrome emerges soon after onset of cocaine use? Neuropsychopharmacology 31(9): 2055 – 2064.
Reder LM, Oates JM, Dickison D, Anderson JR, Gyula F, Quinlan JJ, Ferris JL, Dulik M,
Jefferson BF (2007): Retrograde facilitation under midazolam: the role of general and
specific interference. Psychon Bull Rev 14(2): 261 – 269.
Reece AS (2007): Evidence of accelerated ageing in clinical drug addiction from immune,
hepatic and metabolic biomarkers. Immun Ageing 24;4: 6.
Reeves S, Bench C, Howard R (2002): Ageing and the nigrostriatal dopaminergic system.
Int J Geriatr Psychiatry 17(4): 359 – 370.
Reid MC, Van Ness PH, Hawkins KA, Towle V, Concato J, Guo Z (2006): Light to
moderate alcohol consumption is associated with better cognitive function among older
male veterans receiving primary care. J Geriatr Psychiatry Neurol 19(2): 98 – 105.
Reimer C, Jurkat HB, Mulen B, Stetter F (2001): Zur Problematik der Suchtgefhrdung
von berufsttigen Medizinern. Psychotherapeut 46: 376 – 385.
Reinert DF, Allen JP (2007): The alcohol use disorders identification test: an update of
research findings. Alcohol Clin Exp Res 31(2): 185 – 199.
Reiter S, Schatz M, Hehlmann R (2005): Alkohol und Blut. In: Singer MV, Teyssen S
(Hrsg.): Alkohol und Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl.
S. 410 – 421.
Reitz C, Luchsinger J, Tang MX, Mayeux R (2005): Effect of smoking and time on cognitive function in the elderly without dementia. Neurology 65(6): 870 – 875.
Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007): Relation between
smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology
69(10): 998 – 1005.
Renteln-Kruse W von (Hrsg.) (2004): Medizin des Alterns und des alten Menschen. Darmstadt: Steinkopff.
Rezkalla SH, Kloner RA (2007): Cocaine-induced acute myocardial infarction. Clin Med
Res 5(3): 172 – 176.
Rice VH, Stead LF (2008): Nursing interventions for smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No.: CD001 188. DOI: 10 1002/14 651 858.CD001 188.pub3.
Rich JB, Svoboda E, Brown GG (2006): Diazepam-induced prospective memory impairment and its relation to retrospective memory, attention, and arousal. Hum Psychopharmacol 21(2): 101 – 108.
33
Richards M, Jarvis MJ, Thompson N, Wadsworth ME (2003): Cigarette smoking and
cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public
Health 93(6): 994 – 998.
Richter D, Venzke A, Settelmayer J, Reker T (2002): Hufige Wiederaufnahmen suchtkranker Patienten in die stationre psychiatrische Behandlung – „Heavy User“ oder
chronisch Kranke? Psychiat Prax 29: 364 – 368.
Rickels K (1986): Diskussionsbeitrag. In: Hippius H, Engel RR, Laakmann G (Hrsg.):
Benzodiazepine. Rckblick und Ausblick. Berlin: Springer. S. 136 – 137.
Rickels K, Schweizer E, Case WG, Greenblatt DJ (1990): Long-term therapeutic use of
benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47: 899 – 907.
Rickels K, Garcia-Espana F, Mandos LA, Case GW (2008): Physician Withdrawal Checklist (PWC-20). J Clin Psychopharmacol 28(4): 447 – 451.
Ried LD, Johnson RE, Gettman DA (1998): Benzodiazepine Exposure and Functional
Status in Older People. J Am Geriatr Soc 46: 71 – 76.
Rigotti NA, Munafo MR, Stead LF (2007): Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev Issue 3. Art. No.: CD001 837. DOI:
10 1002/14 651 858.CD001 837.pub2.
Rigotti NA, Munafo MR, Stead LF (2008): Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med 168(18): 1950 – 1960.
Ripamonti C, Fagnoni E, De Conno F (2004): Withdrawal Syndrome After Delayed Tramadol Intake. Am J Psychiatry 161(12): 2326.
Ritter A, Cameron J (2006): A review of the efficacy and effectiveness of harm reduction
strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 25(6): 611 – 624.
Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier
AC, Evans SR, Ellis RJ (2007): The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21(14): 1915 – 1921.
Robin C, Trieger N (2002): Paradoxical reactions to benzodiazepines in intravenous sedation: a report of 2 cases and review of the literature. Anesth Prog 49(4): 128 – 132.
Rodriguez VillamaÇan JC, Blanco CA, Sanchez Sanchez A, Carvajal A, Arias LM, Del Pozo
JG (2000): Withdrawal syndrome after longterm treatment with tramadol. Br J Gen
Pract 50: 406.
Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K (2004): The influence of smoking and
smokeless tobacco use on weight amongst men. J Intern Med 255(1): 102 – 107.
Rommelspacher H (1999): Amphetamine und Entaktogene. In: Gastpar M, Mann K,
Rommelspacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme.
S. 228 – 236.
Rose JE (2006): Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 184(3 – 4): 274 – 285.
Rosenbloom MJ, Sullivan EV, Pfefferbaum A (2003): Using magnetic resonance imaging
and diffusion tenor imaging to asses brain damage in alcoholics. Alcohol Res Health 27:
146 – 152.
Rosenmayr L (1983): Die spte Freiheit. Das Alter – ein Stck bewusst gelebten Lebens.
Berlin: Severin und Siedler.
Roser P, Vollenweider FX, Kawohl W (2010): Potential antipsychotic properties of central
cannabinoid (CB1) receptor antagonists. World J Biological Psychiatry 11(2): 208 – 219.
Rost WD (1992): Psychoanalyse des Alkoholismus. Theorie, Diagnostik, Behandlung.
Stuttgart: Klett-Cotta.
Rothschild AJ (1992): Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry 53(Suppl): 69 – 79.
34
Literatur
Rourke SB, Grant I (1999): The interactive effects of age and length of abstinence on the
recovery of neuropsychological functioning in chronic male alcoholics: a 2-year followup study. J Int Neuropsychol Soc 5: 234 – 246.
Rowe MA, McCrae CS, Campbell JM, Benito AP, Cheng J (2008): Sleep pattern differences
between older adult dementia caregivers and older adult noncaregivers using objective
and subjective measures. J Clin Sleep Med 4(4): 362 – 369.
Rummans T, Davis LJ, Morse RM, Ivnik RJ (1993): Learning and Memory Impairment in
Older, Detoxified, Benzodiazepine-Dependent Patients. Mayo Clin Proc 68: 731 – 737.
Rumpf HJ, Bromisch B, Botzet M, Hill A, Hapke U, John U (1998): Epidemiologie des
Alkoholmissbrauchs im hçheren Alter. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol und Medikamente, Missbrauch und Abhngigkeit im Alter.
Freiburg. Lambertus. S. 29 – 37.
Rustembegovic A, Kundurovic Z, Sapcanin A, Sofic E (2003): A placebo-controlled study
of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. Med Arh 57:
149 – 150.
Ryynanen OP, Kivela SL, Honkanen R, Laippala P, Saano V (1993): Medications and
Chronic Diseases as Risk Factors for Falling Injuries in the Elderly. Scand J Soc Med
21: 264 – 271.
Sachs-Ericsson N, Schmidt NB, Zvolensky MJ, Mitchell M, Collins N, Blazer DG (2009):
Smoking cessation behavior in older adults by race and gender: the role of health problems and psychological distress. Nicotine Tob Res 11(4): 433 – 443.
Saffier K, Colombo C, Brown D, Mundt MP, Fleming MF (2007): Addiction Severity Index
in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat 33(3): 303 – 311.
Sahin HA, Gurvit ICH, Bilgic B, Hanagasi HA, Emre M (2002): Therapeutic effects of an
acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff’s disease.
Clin Neuropharmacol 25: 16 – 20.
Saas T, Gallarda T (2008): Ractions d’agressivit sous benzodiazpines: une revue de la
littrature. Encephale 34(4): 330 – 336.
Salaspuro M (2000): Marker fr Alkoholismus und alkoholassoziierte Organschden. In:
Seitz HK, Lieber CS, Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoholismus –
Alkoholbedingte Organschden. Heidelberg: Barth. 2. Aufl. S. 96 – 124.
Salive ME, Cornoni-Huntley J, LaCroix AZ, Ostfeld AM, Wallace RB, Hennekens CH
(1992): Predictors of smoking cessation and relapse in older adults. Am J Public Health
82(9): 1268 – 1271.
Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H (2009): Cost-effective
primary care-based strategies to improve smoking cessation: more value for money. Arch
Intern Med 169(3): 230 – 235.
Saß AK, Wurm S, Ziese T (2009): Inanspruchnahmeverhalten. In: Bçhm K, Tesch-Rçmer
C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes,
des Deutschen Zentrums fr Altersfragen und des Robert-Koch-Instituts (RKI). Berlin:
RKI. S. 134 – 159.
Satre DD, Mertens J, Aren PA, Weisner C (2003): Contrasting outcomes of older versus
middle-aged and younger adult chemical dependency patients in a managed care program. J Stud Alcohol 64(4): 520 – 530.
Satre DD, Mertens JR, Aren PA, Weisner C (2004): Five-year alcohol and drug treatment
outcomes of older adults versus middle-aged and younger adults in a managed care
program. Addiction 99(10): 1286 – 1297.
35
Savi MM, Obradovi DI, Ugresi ND, Bokonji DR (2005): Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes. Neural Plast 12(4):
289 – 298.
Saxton J, Munro CA, Butters MA, Schramke C, McNeil MA (2000): Alcohol, dementia,
and Alzheimer’s disease: comparison of neuropsychological profiles. J Geriatr Psychiatry
Neurol 13: 141 – 149.
Schufele M, Weyerer S (1999): Psychopharmakagebrauch und Sturzhufigkeit bei Altenund Pflegeheimbewohnern: Eine prospektive epidemiologische Studie in Mannheim.
Euro J Ger 1: 124 – 131.
Schufele M, Weyerer S, Hendlmeier I, Kçhler L (2009): Alkoholbezogene Stçrungen bei
Menschen in Einrichtungen der stationren Altenhilfe: eine bundesweite reprsentative
Studie. Suchttherapie 55(5): 292 – 302.
Scherbaum N (1999): Grundprinzipien der Therapie. In: Gastpar M, Mann K, Rommelspacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 94 – 103.
Scherbaum N (2007): Die Substitutionsbehandlung Opiatabhngiger. Nervenarzt 78:
103 – 110.
Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, Fisch HU, Pearlson GD
(2006): Decreased frontal white-matter volume in chronic substance abuse. Int J Neuropsychopharmacol 9(2): 147 – 153.
Schmidbauer W (1997): Hilflose Helfer. ber die seelische Problematik der helfenden
Berufe. Reinbek: Rowohlt. berarbeitete und erweiterte Neuausgabe.
Schmidt KS, Gallo JL, Ferri C, Giovannetti T, Sestito N, Libon DL, Schmidt PL (2005): The
neuropsychological profile of alcohol-related dementia suggests cortical and subcortical
pathology. Dement Geriatr Cogn Disord 20: 286 – 291.
Schmidt LG (2005): Biologische Marker des Alkoholismus und alkoholassoziierte Organschden. In: Singer MV, Teyssen S (Hrsg.): Alkohol und Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl. S. 121 – 129.
Schmitt M, Re S (2004): Partnerschaft im Alter. In: Kruse A, Martin M (Hrsg.): Enzyklopdie der Gerontologie. Bern: Huber. S. 373 – 386.
Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Gerard Moeller F (2009): Highdose naltrexone therapy for cocaine-alcohol dependence. Am J Addict 18(5): 356 – 362.
Schofield I, Kerr S, Tolson D (2007): An exploration of the smoking-related health beliefs
of older people with chronic obstructive pulmonary disease. J Clin Nurs 16(9):
1726 – 1735.
Schonfeld L, Dupree LW (1995): Treatment Approaches for Older Problem Drinkers. Int
J Addict 30: 1819 – 1842.
Schutte KK, Moos RH, Brennan PL (2006): Predictors of untreated remission from late-life
drinking problems. J Stud Alcohol 67(3): 354 – 362.
Schutte KK, Brennan PL, Moos RH (2009): Treated and untreated remission from problem
drinking in late life: post-remission functioning and health-related quality of life. Drug
Alcohol Depend 99(1 – 3): 150 – 159.
Schwabe U, Paffrath D (Hrsg.) (2009): Arzneiverordnungsreport 2009 Berlin: Springer.
Schweizer E, Case WG, Rickels K (1989): Benzodiazepine Dependence and Withdrawal in
Elderly Patients. Am J Psychiatry 146: 529 – 531.
Schweizer E, Rickels K, Case WG, Greenblatt DJ (1990): Long-Term Therapeutic Use of
Benzodiazepines. II. Effects of Gradual Taper. Arch Gen Psychiatry 47: 908 – 915.
Seitz HK, Osswald BR, Pçschl G (2000 a): Alkohol und Alter. In: Seitz HK, Lieber CS,
Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoholismus – Alkoholbedingte Organschden. Heidelberg: Barth. 2. Aufl. S. 159 – 170.
36
Literatur
Seitz HK, Lieber CS, Simanowski UA (Hrsg.) (2000 b): Handbuch Alkohol – Alkoholismus
– Alkoholbedingte Organschden. Heidelberg: Barth. 2. Aufl.
Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundstrçm P,
Ascherio A (2010): Combined effects of smoking, anti-EBNA antibodies, and HLADRB1*1501 on multiple sclerosis risk. Neurology 74: 1365 – 1371.
Singer MV, Teyssen S (Hrsg.) (2005): Alkohol und Alkoholfolgekrankheiten. Heidelberg:
Springer. 2. Aufl. S. 410 – 421.
Singer EJ, Valdes-Sueiras M, Commins D, Levine A (2010): Neurologic presentations of
AIDS. Neurol Clin 28(1): 253 – 275.
Sivolap YP (2005): The current state of S. S. Korsakov’s concept of alcoholic polyneuritic
psychosis. Neuroscience and Behavioral Physiology 35(9): 977 – 982.
Skeie I, Brekke M, Lindbaek M, Waal H (2008): Somatic health among heroin addicts
before and during opioid maintenance treatment: a retrospective cohort study. BMC
Public Health 31(8): 43.
Skurtveit S, Furu K, Bramness JG, Tverdal A (2008): Benzodiazepine use in all alcohol
consumers predicts use of opioids in patients 20 years later – a follow-up study of 13 390
men and women aged 40 – 42 years. Pharmacoepidemiol Drug Saf 17(9): 926 – 933.
Sleath B, Thorpe J, Landerman LR, Doyle M, Clipp E (2005): African-American and white
caregivers of older adults with dementia: differences in depressive symptomatology and
psychotropic drug use. J Am Geriatr Soc 53(3): 397 – 404.
Smith DM, Atkinson RM (1995): Alcoholism and dementia. Int J Addict 30: 1843 – 1869.
Smith PF (2005): The safety of cannabinoids for the treatment of multiple sclerosis. Expert
Opin Drug Saf 4(3): 443 – 456.
Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P (2005): A method for
determining the magnitude of change across different cognitive functions in clinical
trials: the effects of acute administration of two different doses alprazolam. Hum Psychopharmacol 20(4): 263 – 273.
Solfrizzi V, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Baldassarre G, Scapicchio P, Scafato E, Amodio M, Capurso A, Panza F; Italian Longitudinal Study on
Aging Working Group (2007): Alcohol consumption, mild cognitive impairment, and
progression to dementia. Neurology 68(21): 1790 – 1799.
Solty H, Crockford D, White WD, Currie S (2009): Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients. Can J Psychiatry
54(1): 36 – 45.
Sorock GS, Shimkin EE (1988): Benzodiazepine Sedatives and the Risk of Falling in a
Community-Dwelling Elderly Cohort. Arch Intern Med 148: 2441 – 2444.
Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D
(2003): Lack of relationship between long-term use of benzodiazepines and escalation to
high dosages. Psychiatr Serv 54(7): 1006 – 1011.
Soyka M (2000): Verwirrtheitssyndrome bei Alkoholabhngigkeit – Differentialdiagnose
und Therapie. In: Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G,
Wchtler C (Hrsg.): Angst-, Sucht- und Anpassungsstçrungen im Alter. Schriftenreihe
der Deutschen Gesellschaft fr Gerontopsychiatrie und -psychotherapie Bd. 1. Stuttgart:
Kohlhammer. S. 285 – 294.
Soyka M (2005): Alkohol und Psychiatrie. In: Singer MV, Teyssen S (Hrsg.): Alkohol und
Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl. S. 496 – 508.
Soyka M (2008): Drogen- und Medikamentenabhngigkeit. In: Mçller HJ, Laux G, Kapfhammer HP (Hrsg.): Psychiatrie und Psychotherapie. Bd. 2. Heidelberg: Springer.
3. Aufl. S. 187 – 241.
37
Speckens AEM, Heeren TJ, Rooijmans HGM (1991): Alcohol abuse among elderly patients
in a general hospital as identified by the Munich Alcoholism Test. Acta Psychiatr Scand
83: 460 – 462.
Spiegelhalder K, Perlis ML, Hajak G, Riemann D (2009): Schlafstçrungen. In: Vorderholzer
U, Hohagen F (Hrsg.): Therapie psychischer Stçrungen. State of the Art 2008/2009.
Mnchen: Urban & Fischer. 4. Aufl. S. 307 – 320.
Spira AP, Edelstein BA (2006): Behavioral interventions for agitation in older adults with
dementia: an evaluative review. Int Psychogeriatr 8(2): 195 – 225.
Stalnaker TA, Takahashi Y, Roesch MR, Schoenbaum G (2009): Neural substrates of
cognitive inflexibility after chronic cocaine exposure. Neuropharmacology 56(Suppl
1): 63 – 72.
Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F (2005): Effects of moderate alcohol
consumption on cognitive function in women. N Engl J Med 352: 245 – 253.
Stapleton JM, Eckardt MJ, Martin PR, Adinoff B, Roehrich L, Bone GA, Rubinow DR,
Linnoila M, (1988): Treatment of alcholic organic brain syndrome with the serotonine
reuptake inhibitor fluvoxamine: a preliminary study. Adv Alcohol Subst Abuse 7: 47 – 51.
Staudinger UM (2000): Viele Grnde sprechen dagegen und trotzdem fhlen viele Menschen sich wohl: Das Paradox des subjektiven Wohlbefindens. Psychol Rundschau 51:
185 – 197.
Staudinger UM, Baumert J (2007): Bildung und Lernen jenseits der 50: Plastizitt und
Realitt. In: Gruss P (Hrsg.): Die Zukunft des Alterns. Mnchen: Beck. S. 240 – 257.
Stead LF, Lancaster T (2007): Interventions to reduce harm from continued tobacco use.
Cochrane Database Syst Rev Issue 3. Art. No.: CD005 231. DOI: 101002/14651858.CD005231.pub2.
Stead LF, Perera R, Lancaster T (2007): A systematic review of interventions for smokers
who contact quitlines. Tob Control 16 (Suppl 1): i3 – 8.
Stead LF, Bergson G, Lancaster T (2008 a): Physician advice for smoking cessation. Cochrane Database Syst Rev Issue 2. Art. No.: CD000 165. DOI: 101002/14651858.CD000165.pub3.
Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008 b): Nicotine replacement therapy
for smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No.: CD000 146. DOI:
101002/14651858.CD000146.pub3.
Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, Wyse BW, WelshBohmer KA, Breitner JC (2000): Prevalence of depression and its treatment in an elderly
population: the Cache County study. Arch Gen Psychiatry 57(6): 601 – 607.
Stephens DN, Duka T (2008): Review. Cognitive and emotional consequences of binge
drinking: role of amygdala and prefrontal cortex. Philos Trans R Soc Lond B Biol Sci
363(1507): 3169 – 3179.
Stephens R, Ling J, Heffernan TM, Heather N, Jones K (2008): A review of the literature
on the cognitive effects of alcohol hangover. Alcohol Alcohol 43(2): 163 – 170.
Stetter F (2000): Psychotherapie. In: Zernig G, Saria A, Kurz M, O’Malley SS (Hrsg.):
Handbuch Alkoholismus. Universittsklinik fr Psychiatrie Innsbruck. S. 99 – 142.
Stewart R, Niessen WJ, Broer J, Snijders TA, Haaijer-Ruskamp FM, Meyboom-De Jong B
(2007): General Practitioners reduced benzodiazepine prescriptions in an intervention
study: a multilevel application. J Clin Epidemiol 60(10): 1076 – 1084.
St John PD, Montgomery PR, Tyas SL (2009): Alcohol misuse, gender and depressive
symptoms in community-dwelling seniors. Int J Geriatr Psychiatry 24(4): 369 – 375.
Stçhr M (2005): Die Wahrheit ber Anti-Aging. Frankfurt/M.: Eichborn.
38
Literatur
Stolle, Martin; Sack, Peter-Michael; Thomasius, Rainer (2009): Rauschtrinken im Kindesund Jugendalter: Epidemiologie, Auswirkungen und Intervention. Dtsch Arztebl Int
106(19): 323 – 328.
Stumpf W (2003): Wenn Junkies in die Jahre kommen. In: Seeberger B, Braun A (Hrsg.):
Wie die anderen altern. Zur Lebenssituation alter Menschen am Rande der Gesellschaft.
Frankfurt/M.: Mabuse. S. 143 – 147.
Stuppck CH, Whitworth AB, Stuppck PCC (2000): Alkoholentzugssyndrom. In: Zernig
G, Saria A, Kurz M, O’Malley SS (Hrsg.): Handbuch Alkoholismus. Universittsklinik
fr Psychiatrie Innsbruck. S. 71 – 80.
Subkowski P (2000): Die psychoanalytische Sicht der Abhngigkeitserkrankungen. Psychotherapeut 45: 253 – 266.
Subkowski P (2009): Perversion und Suchtentwicklung. In: Bilitza KW (Hrsg.): Psychotherapie der Sucht. Psychoanalytische Beitrge zur Praxis. Gçttingen: Vandenhoeck &
Ruprecht, 2. Aufl. S. 91 – 100.
Sullivan EV, Marsh L (2003): Hippocampal volume deficits in alcoholic Korsakoff’s syndrome. Neurology 61: 1716 – 1719.
Sullivan EV, Pfefferbaum A (2005): Neurocircuity in alcoholism: a substrate of disruption
and repair. Psychopharmacology 180: 583 – 594.
Surendrakumar D, Dunn M, Roberts CJC (1992): Hospital Admission and the Start of
Benzodiazepine Use. Br Med J 304: 881.
Sweitzer MM, Donny EC, Dierker LC, Flory JD, Manuck SB (2008): Delay discounting
and smoking: Association with the Fagerstrçm Test for Nicotine Dependence but not
cigarettes smoked per day. Nicotine Tob Res 10(10): 1571 – 1575.
Tait RJ, Hulse GK, Waterreus A, Flicker L, Lautenschlager NT, Jamrozik K, Almeida OP
(2006): Effectiveness of a smoking cessation intervention in older adults. Addiction
102(1): 148 – 155.
Tait RJ, Hulse GK, Waterreus A, Flicker L, Lautenschlager NT, Jamrozik K, Almeida OP
(2008): Two-Year Outcomes From a Cessation of Smoking Intervention in Older Adults.
Journal of Smoking Cessation 3(2): 101 – 109. DOI 10 1375/jsc.3. 2. 101.
Tait RJ, Siru R (2009): Executive cognitive function and cessation of smoking among older
adults. Aging Health 5(1): 33 – 37.
Tassain V, Attal N, Fletcher D, Brasseur L, Dgieux P, Chauvin M, Bouhassira D (2003):
Long term effects of oral sustained release morphine on neuropsychological performance
in patients with chronic non-cancer pain. Pain 104(1 – 2): 389 – 400.
Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR (1994): Lack of Cognitive
Recovery Following Withdrawal From Long-Term Benzodiazepine Use. Psychol Med
24: 203 – 213.
Taylor DH Jr, Hasselblad V, Henley SJ, Thun MJ, Sloan FA (2002): Benefits of smoking
cessation for longevity. Am J Public Health 92(6): 990 – 996.
Tedstone D, Coyle K (2004): Cognitive impairments in sober alcoholics: performance on
selective and divided attention tasks. Drug Alcohol Depend 75: 277 – 286.
Teising M (2000): Die Angst vor dem Pflegefall. Psychodynamische Betrachtungen. Wien,
Facultas.
Termorshuizen F, Krol A, Prins M, van Ameijden EJ (2005): Long-term outcome of chronic
drug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol 161(3):
271 – 279.
Tesch-Rçmer C, Wurm S (2009): Lebenssituationen lter werdender und alter Menschen in
Deutschland. In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit
im Alter. Beitrge zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Ver-
39
çffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums fr Altersfragen
und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 113 – 120.
Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ (2008): Wernicke’s
encephalopathy: „plus ca change, plus c’est la meme chose“. Alcohol Alcohol 43(2):
180 – 186.
Thun MJ, Colditz GA (1998): Invited Commentary on „Early and Late Weight Gain
following Smoking Cessation in the Lung Health Study“. Am J Epidemiol 148(9):
831 – 832.
Tinetti ME, Speechley M, Ginter SF (1988): Risk Factors for Falls Among Elderly Persons
Living in the Community. N Engl J Med 319: 1701 – 1707.
Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND
(2007 a): Widespread disruption in brain activation patterns to a working memory task
during cocaine abstinence. Brain Res 1171: 83 – 92.
Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND
(2007 b): Thalamo-cortical dysfunction in cocaine abusers: implications in attention and
perception. Psychiatry Res 155(3): 189 – 201.
Tçnne U, Hiltunen AJ, Vikander B, Engelbrektsson K, Bergmann H, Bergman I, Leifman
H, Borg S (1995): Neuropsychological Changes During Steady-State Drug Use, Withdrawal and Abstinence in Primary Benzodiazepine-Dependent Patients. Acta Psychiatr
Scand 91: 299 – 304.
Tonstad S (2009): Cigarette smoking, smoking cessation, and diabetes. Diabetes Res Clin
Pract 85(1): 4 – 13.
Trollor JN, Anderson TM, Sachdev PS, Brodaty H, Andrews G (2007): Prevalence of
mental disorders in the elderly: the Australian National Mental Health and Well-Being
Survey. Am J Geriatr Psychiatry 15(6): 455 – 466.
Truelsen T, Thudium D, Gronbaek M, Copenhagen City Heart Study (2002): Amount and
type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 59:
1313 – 1319.
Tsai MJ, Tsai YH, Huang YB (2007): Compulsive activity and anterograde amnesia after
zolpidem use. Clin Toxicol 45(2): 179 – 181.
Tsoh JY, Humfleet GL, MuÇoz RF, Reus VI, Hartz DT, Hall SM (2000): Development of
major depression after treatment for smoking cessation. Am J Psychiatry 157(3):
368 – 374.
Tsunoda K, Uchida H, Suzuki T, Watanabe K, Yamashima T, Kashima H (2010): Effects of
discontinuing benzodiazepine-derivative hypnotics on postural sway and cognitive
functions in the elderly. Int J Geriatr Psychiatry. DOI: 10 1002/gps. 2465.
Tverdal A, Bjartveit K (2006): Health consequences of reduced daily cigarette consumption. Tob Control 15(6): 472 – 480.
Twardella D, Kpper-Nybelen J, Rothenbacher D, Hahmann H, Wsten B, Brenner H
(2004): Short-term benefit of smoking cessation in patients with coronary heart disease:
estimates based on self-reported smoking data and serum cotinine measurements. Eur
Heart J 25(23): 2101 – 2108.
Twardella D, Brenner H (2005): Lack of training as a central barrier to the promotion of
smoking cessation: a survey among general practitioners in Germany. Eur J Public Health
15(2): 140 – 145.
Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H (2006 a): The
diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a
retrospective cohort study. J Clin Epidemiol 59(1): 82 – 89.
40
Literatur
Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H (2006 b): The
impact of body weight on smoking cessation in German adults. Preventive Medicine 42:
109 – 113.
Twardella D, Rothenbacher D, Hahmann H, Wsten B, Brenner H (2006 c): The Underestimated Impact of Smoking and Smoking Cessation on the Risk of Secondary Cardiovascular Disease Events in Patients With Stable Coronary Heart Disease: Prospective
Cohort Study. JACC 4: 884 – 892.
Twardella D, Brenner H (2007): Effects of practitioner education, practitioner payment and
reimbursement of patients’ drug costs on smoking cessation in primary care: a cluster
randomised trial. Tob Control 16(1): 15 – 21.
Tyrer P, Murphy S, Riley P (1990): The Benzodiazepine Withdrawal Symptom Questionnaire. J Affect Disord 19(1): 53 – 61.
Tyrer P (1993 b): Pharmacological differences in the dependence potential of benzodiazepines. In: Hallstrçm C (Ed.): Benzodiazepine Dependence. Oxford: Oxford Univ. Press.
S. 221 – 237.
Uchtenhagen A, Zieglgnsberger W (Hrsg.) (2000): Suchtmedizin. Konzepte, Strategien
und therapeutisches Management. Mnchen: Urban & Fischer.
Ullmann R (2010): Substanzabhngigkeit und ADHS bei Erwachsenen. Suchttherapie 11:
6 – 7.
Unal B, Critchley J, Capewell S (2003): Impact of smoking reduction on coronary heart
disease mortality trends during 1981 – 2000 in England and Wales. Tob Induc Dis 1(3):
185.
Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC (2004): Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry
161(4): 654 – 661.
Vanable PA, King AC, de Wit H (2000): Psychometrische Erfassungsinstrumente. In: Zernig G, Saria A, Kurz M, O’Malley SS (Hrsg.): Handbuch Alkoholismus. Universittsklinik fr Psychiatrie Innsbruck. S. 41 – 52.
Vandivort R, Teich JL, Cowell AJ, Chen H (2009): Utilization of substance abuse treatment
services under Medicare, 2001 – 2002. J Subst Abuse Treat 36(4): 414 – 419.
van Hulten R, Bart Teeuw K, Bakker A, Leufkens HG (2003): Initial 3-month usage
characteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J Clin
Pharmacol 58: 689 – 694.
van Vliet P, van der Mast RC, van den Broek M, Westendorp RGJ, de Craen AJM (2009):
Use of benzodiazepines, depressive symptoms and cognitive function in old age. Int
J Geriatr Psychiatry 24: 500 – 508.
Vaupel JW, von Kistowski KG (2007): Die Plastizitt menschlicher Lebenserwartung und
ihre Konsequenzen. In: Gruss P (Hrsg.): Die Zukunft des Alterns. Mnchen: Beck.
S. 51 – 78.
Verdejo A, Toribio I, Orozco C, Puente KL, Prez-Garca M (2005): Neuropsychological
functioning in methadone maintenance patients versus abstinent heroin abusers. Drug
Alcohol Depend 78(3): 28 328 – 28 328.
Verster JC, Volkerts E (2004): Clinical pharmacology, clinical efficacy, and behavioral
toxicity of alprazolam: a review of the literature. CNS Drug Rev 10(1): 45 – 76.
Verwey B, Muntendam A, Ensing K, Essink G, Pasker-de Jong PC, Willekens FL, Zitman
FG (2005): Clinically relevant anterograde amnesia and its relationship with blood levels
of benzodiazepines in suicide attempters who took an overdose. Prog Neuropsychopharmacol Biol Psychiatry 29(1): 47 – 53.
Victor M (1994): Alcoholic dementia. Can J Neurol Sci 21: 88 – 99.
41
Vogt I (2009 b): ltere Drogenabhngige in vier europischen Lndern und ihr Hilfebedarf
(SDDCARE), Zwischenergebnisse. Vortrag bei der Fachtagung „ltere Drogenabhngige
– Versorgungskonzepte an der Schnittstelle zwischen Sucht- und Altenhilfe“ am 22. Oktober 2009 in Mnchen. http://www.paritaet-bayern.de/webcode/link.php?id=954 –
Zugriff 30. 04. 2010.
Vogt I (Hrsg.) (2011): Auch Drogenabhngige altern. Frankfurt: Fachhochschul-Verlag (im
Druck).
Vçlger G, von Welck K (Hrsg.) (1982): Rausch und Realitt. Drogen im Kulturvergleich.
Drei Bnde. Reinbek: Rohwolt.
Volkow ND, Wang GJ, Fowler JS, Telang F (2008): Overlapping neuronal circuits in
addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol
Sci 363(1507): 3191 – 3200.
Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J,
Lerman C (2006): A randomized controlled trial of financial incentives for smoking
cessation. Cancer Epidemiol Biomarkers Prev 15(1): 12 – 18.
von Ferber L, Ihle P, Kçster I, Krappweis J (1992): Abhngigkeit im Spiegel der Verwaltungsdaten einer Ortskrankenkasse aus dem Jahre 1983 unter besonderer Bercksichtigung der Abhngigkeit bei rztlich verordneten Medikamenten. In: Deutschen Hauptstelle gegen die Suchtgefahren (Hrsg.): Medikamentenabhngigkeit. Freiburg:
Lambertus. S. 43 – 58.
von Kondratowitz HJ von (1999): Sozialanthropologie. In: Jansen B, Karl F, Radebold H,
Schmitz-Scherzer R (Hrsg.): Soziale Gerontologie. Weinheim: Beltz. S. 106 – 125.
Vorderholzer U, Hohagen F (1998): Schlafstçrungen und Hypnotikagebrauch im hçheren
Lebensalter. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol und
Medikamente, Missbrauch und Abhngigkeit im Alter. Freiburg: Lambertus. S. 73 – 85.
Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K (2003): Long-term outcome after
benzodiazepine withdrawal treatment in subjects with complicated dependence. Drug
Alcohol Depend 70: 309 – 314.
Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton PK, He J (2004):
The risk for mild kidney function decline associated with illicit drug use among hypertensive men. Am J Kidney Dis 43(4): 629 – 35.
Wadsworth EJ, Moss SC, Simpson SA, Smith AP (2005): Psychotropic medication use and
accidents, injuries and cognitive failures. Hum Psychopharmacol 20(6): 391 – 400.
Waern M (2003): Alcohol dependence and misuse in elderly suicides. Alcohol Alcohol
38(3): 249 – 254.
Wahl WW, Tesch-Rçmer C (Hrsg.) (2000): Angewandte Gerontologie in Schlsselbegriffen.
Stuttgart: Kohlhammer.
Wahl WW, Heyl V (2004): Gerontologie – Einfhrung und Geschichte. Stuttgart: Kohlhammer.
Walther E (1982): Kulturhistorisch-ethnologischer Abriss ber den Gebrauch von Tabak.
In: Vçlger G, von Welck K (Hrsg.): Rausch und Realitt. Drogen im Kulturvergleich.
Band 1. Reinbek: Rohwolt. S. 374 – 386.
Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D (2008): Cut down to
quit’ with nicotine replacement therapies in smoking cessation: a systematic review of
effectiveness and economic analysis. Health Technol Assess 12(2): iii–iv, ix–xi, 1 – 135.
Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE (1998): Diabetic ketoacidosis associated with cocaine use. Arch Intern Med 158(16): 1799 – 1802.
Weakland JH, Herr JJ (1988): Beratung lterer Menschen und ihrer Familien. Bern: Huber.
2. Aufl.
42
Literatur
Weeß HG, Steiberg R, Pritzel M (1994): Kognitive Nebenwirkungen bei Langzeit high-dose
Diazepam-Mißbrauch. In: Mayer G (Hrsg.): Jahrbuch Schlafmedizin in Deutschland
1994. Mnchen: MMV. S. 77 – 80.
Weih M, Wiltfang J (2006): Demenz – Grundlagen. In: Oswald WD, Lehr U, Sieber C,
Kornhuber J (Hrsg.): Gerontologie. Stuttgart: Kohlhammer, 3. Aufl. S. 132 – 138.
West R (2005): Time for a change: putting the Transtheoretical (Stages of Change) Model
to rest. Addiction 100: 1036 – 1039.
Wetterling T, Driessen M, Kanitz RD, Junghanns K (2001): The severity of alcohol withdrawal is not age dependent. Alcohol Alcohol 36(1): 75 – 78.
Wetterling T, Kugler C (2005): ltere Suchtkranke im psychiatrischen Krankenhaus. Z
Gerontopsychol psychiatr 19(4): 195 – 200.
Weyerer S (1993): Die psychopharmakologische Behandlung lterer Menschen in der Allgemeinbevçlkerung und in Heimen: Epidemiologische Befunde. Sucht 39: 180 – 186.
Weyerer S, Schufele M, Zimber A (1998): Epidemiologie des Psychopharmakagebrauchs
im hçheren Alter. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol
und Medikamente, Missbrauch und Abhngigkeit im Alter. Freiburg: Lambertus.
S. 38 – 49.
Weyerer S, Schufele M, Hendlmeier I (2006): Alkoholmissbrauch und -abhngigkeit bei
Bewohnern und Bewohnerinnen in Altenpflegeheimen: Reprsentative Ergebnisse aus der
Stadt Mannheim. Z Gerontopsychol psychiatr 19 (4): 297 – 236.
Weyerer S, Schufele M, Eifflaender-Gorfer S, Kçhler L, Maier W, Haller F, CvetanovskaPllashiniku G, Pentzek M, Fuchs A, van den Bussche H, Zimmermann T, Eisele M, Bickel
H, Mçsch E, Wiese B, Angermeyer MC, Riedel-Heller SG; for the German AgeCoDe
Study group (2009): At-risk alcohol drinking in primary care patients aged 75 years and
older. Int J Geriatric Psychiatry. 24(12):1376 – 85
Whitson HE, Heflin MT, Burchett BM (2006): Patterns and predictors of smoking cessation in an elderly cohort. J Am Geriatr Soc 54(3): 466 – 471.
WHO – World Health Organization (2005): Internationale Klassifikation der Funktionsfhigkeit, Behinderung und Gesundheit. Kçln: Deutsches Institut fr Medizinische Dokumentation und Information (DIMDI). http://www.dimdi.de/dynamic/de/klassi/downloadcenter/icf/endfassung/icf_endfassung-2005-10- 01.pdf – Zugriff 30. 04. 2010.
WIdO – Wissenschaftliches Institut der AOK (2009): Arzneiverbrauch nach Arztgruppen
2008. Verordnungen, Umstze, definierte Tagesdosen aufgegliedert nach Arztgruppen.
Berlin: WIdO.
Wilhelm J, Bayerlein K, Hillemacher T, Reulbach U, Frieling H, Kromolan B, Degner D,
Kornhuber J, Bleich S (2006): Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J Neural Trans 113: 357 – 363.
Wilson KC, Copeland JR, Taylor S, Donoghue J, McCracken CF (1999): Natural history of
pharmacotherapy of older depressed community residents. The MRC-ALPHA Study. Br J
Psychiatry 175: 439 – 443.
Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, O’Hara P,
Owens GR, Rand CS, Tashkin DP (1998): Effect of weight gain on pulmonary function
after smoking cessation in the Lung Health Study. Am J Respir Crit Care Med 157(3 Pt
1): 866 – 872.
Witt R (1998): Therapie mit abhngigen Senioren in der Fachklinik. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol und Medikamente, Missbrauch und
Abhngigkeit im Alter. Freiburg: Lambertus. S. 136 – 141.
43
Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, Wang GJ,
Volkow ND, Goldstein RZ (2009): The neuropsychology of cocaine addiction: recent
cocaine use masks impairment. Neuropsychopharmacology 34(5): 1112 – 1122.
Wojnar M, Wasilewski D, Zmigrodzka I, Grobel I (2001): Age-related differences in the
course of alcohol withdrawal in hospitalized patients. Alcohol Alcohol 36(6): 577 – 583.
Wolf R, Grohmann B, Mçssner B, Poser W, Rther E, Schmidt LG (1994): Medikamentenmissbrauch und Abhngigkeit. In: Grohmann R, E. Rther E, Schmidt LG (Hrsg.):
Unerwnschte Wirkungen von Psychopharmaka. Ergebnisse der AMP-Studie. Berlin:
Springer. S. 278 – 308.
Wçlfling K, Bhler M, Lemnager T, Mçrsen C, Mann K (2009): Glcksspiel- und Internetsucht. Nervenarzt 80(9): 1030 – 1039.
Wolffgramm J, Heyne A (2005): Ratten als Langzeitkonsumenten von Nikotin: Der Weg
zur Nikotinsucht. In: Batra A (Hrsg.): Tabakabhngigkeit. Wissenschaftliche Grundlagen
und Behandlung. Stuttgart: Kohlhammer. S. 30 – 41.
Wolter DK (2004): Gerontopsychiatrische Tageskliniken. In: Eikelmann B, Reker T (Hrsg.):
Psychiatrie und Psychotherapie in der Tagesklinik. Stuttgart. Kohlhammer. S. 83 – 96.
Wolter DK (2006): Alkohol-assoziierte kognitive Beeintrchtigungen – ein Kontinuum von
subklinischer Leistungsminderung bis zur schweren Demenz? Z Gerontopsychol psychiatr 19(4): 207 – 220.
Wolter DK (2010): Schlaf- und Beruhigungsmittel im Alter. Psychopharmakotherapie
17(1): 39 – 46.
Wolter-Henseler DK: (1996): Zur Problematik der Benzodiazepinverordnung im Alter.
Psycho 22: 454 – 464.
Wolters EC, van der Werf YD, van den Heuvel OA (2008): Parkinson’s disease-related
disorders in the impulsive-compulsive spectrum. J Neurol 255(Suppl 5): 48 – 56.
Won A, Lapane KI, Vallow S, Schein J, Morris JN, Lipsitz LA (2006): Long term effects of
analgesics in a population of elderly nursing home residents with persistent nonmalignant pain. J Gerontol A Biol Sci Med Sci 61(2): 165 – 169.
Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008): Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37(5): 547 – 552.
Woods SP, Moore DJ, Weber E, Grant I (2009): Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19(2): 152 – 168.
Wright CB, Elkind MS, Rundek T, Boden-Albala B, Paik MC, Sacco RL (2006 a): Alcohol
intake, carotid plaque, and cognition: The Northern Manhattan Study. Stroke 37:
1160 – 1164.
Wright CB, Elkind MS, Luo X, Paik MC, Sacco RL (2006 b): Reported alcohol consumption and cognitive decline: The northern Manhattan study. Neuroepidemiology 27(4):
201 – 207.
Wu P, Wilson K, Dimoulas P, Mills EJ (2006): Effectiveness of smoking cessation therapies:
a systematic review and meta-analysis. BMC Public Health 11;6: 300.
Wbbels R (1989): Suchterkrankungen im Pflegeheim. In: Hamburgische Landesstelle
gegen die Suchtgefahren (Hrsg.): Abhngigkeit im Alter. Mçglichkeiten und Grenzen
der Hilfe. Hamburg. S. 31 – 35.
Wurm S, Lampert T, Menning S (2009 a): Subjektive Gesundheit. In: Bçhm K, Tesch-Rçmer
C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitrge zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes,
des Deutschen Zentrums fr Altersfragen und des Robert-Koch-Instituts (RKI). Berlin:
RKI. S. 79 – 91.
44
Literatur
45
Wurm S, Engstler H, Tesch-Rçmer C (2009 b): Ruhestand und Gesundheit. In: Kochsiek K
(Hrsg.): Altern und Gesundheit. (Altern in Deutschland Band 7). Nova Acta Leopoldina
NF 105, Nr. 369: 81 – 192. Halle (Saale): Deutsche Akademie der Naturforscher Leopoldina/Stuttgart: Wissenschaftliche Verlagsgesellschaft.
Wurst FM, Seidl S, Alt A (2000): thylglukuronid – der direkte thanolmetabolit, seine
Bedeutung als Alkoholkonsum- und Rckfallmarker, Nachweismethoden und Perspektiven. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoholismus – Alkoholbedingte Organschden. Heidelberg: Barth. 2. Aufl. S. 125 – 129.
Yang JC, Huang D, Hser YI (2006): Long-term morbidity and mortality among a sample of
cocaine-dependent black and white veterans. J Urban Health 83(5): 926 – 940.
Yates WR, Nguyen MH, Warnock JK (2001): Tramadol dependence with no history of
substance abuse. Am J Psychiatry 158(6): 964.
Zanjani F, Mavandadi S, TenHave T, Katz I, Durai NB, Krahn D, Llorente M, Kirchner J,
Olsen E, Van Stone W, Cooley S, Oslin DW (2008): Longitudinal course of substance
treatment benefits in older male veteran at-risk drinkers. J Gerontol A Biol Sci Med Sci
63(1): 98 – 106.
Zank S, Peters M, Wilz G (2010): Klinische Psychologie und Psychotherapie des Alters.
Stuttgart: Kohlhammer.
Zeyfang, Hagg-Grn, Nikolaus (2008): Basiswissen Medizin des Alterns und des alten
Menschen. Berlin: Springer.
Zieglgnsberger W, Hçllt V (2000): Opiate und Opiode. In: Uchtenhagen A, Zieglgnsberger W (Hrsg.): Suchtmedizin. Mnchen: Urban & Fischer. S. 87 – 97.
Zitman FG, Couve JE (2001): Chronic benzodiazepine use in general practice patients
with depression: an evaluation of controlled treatment and taper-off. Report on behalf of
the Dutch Chronic Benzodiazepine Working Group. Br J Psychiatry 178: 317 – 324 (auch
in: Couve JA: Towards a treatment of chronic benzodiazepine users suffering from
depression. Dissertation Universitt Leiden. S. 19 – 34).
Zutt J (1958): Zur Anthropologie der Sucht. Nervenarzt 29(10): 439 – 445.

Wolter_Sucht im Alter_WEB-Literatur_AK_4 1..45

Transcrição

Documentos relacionados

Fakten zum Rauchen

Beipackzettel LA ROCHE-POSAY Effaclar H - shop

Investigation of Single Photon Emission Computed Tomography

international organic wine award 2016 Award: Gold Dienheim

FRISUREN-SPECIAL

Das Wortfeld „Kleidung“

Klasse 8b - Be Smart – Don`t Start

Meine Herren, passen Sie auf Ihre Garderobe auf!

Herunterladen